The Roots Analysis team is putting in its best effort to offer our clients / readers a reliable source of information, regarding how the pharmaceutical and biotech sectors are coping in the midst of the COVID-19 pandemic. Our intention is to generate realistic insights, based on a variety of factors, which are anticipated to influence both prevalent and future market dynamics. Reach out to us for any help.

Cold Chain Logistics Market for Healthcare: Focus on Cell Therapies, Vaccines, and Human Organs, 2018-2030

  • Lowest Price Guaranteed From USD 3,499

  • Published
    September 2018

  • Pages
    497

  • View Count
    2075

Example Insights

 

 

Overview

The origins of the cold chain for transportation of temperature sensitive products can be traced back to 1797, when British fishermen first used natural ice to preserve their fish stock.Presently, a wide variety of pharmaceutical products, such as biologics, vaccines, human organs for transplantation and certain conventional pharmacological interventions as well, are temperature sensitive and require freezing / cryogenic holding temperatures for transport. In fact, over 95% of all approved biologics and 90% of all vaccines are cold chain dependent. The COVID-19 pandemic has increased the number of development programs for vaccines, significantly raising the demand for cold chain service providers in the foreseen future. In order to cope with increased inflow of patients, countries must prepare sustainable cold chain logistics to deliver / supply COVID-19 vaccine to different parts of globe. Other healthcare products which are required to be shipped / stored under specific temperature conditions include aerosols, blood plasma samples, certain types of diagnostics kits, fertility samples, and laboratory specimens. For some products, even the slightest variations in temperature / storage conditions can adversely alter their integrity and / or viability.

Over the years, the growing demand for such products has necessitated the need for well-defined infrastructure and protocols to support cold chain dependent logistics operations. Further, stakeholders in this segment of the industry have designed and established a variety of innovative solutions to serve the evolving demands of the healthcare sector. Moreover, connected cold chain solutions have been observed to offer a variety of advantages over conventional methodologies, such as automation of most of the steps and elimination of human handling errors that are associated with human intervention.

In addition, the industry has witnessed several facility / capability expansions and acquisitions owing to an increasing demand for cold chain logistics services, which is indicative of the growing interest of stakeholders in this particular type of supply chain. Given the recent technical breakthroughs and advances, and the steadily rising demand for biopharmaceuticals, the reliance on cold chain is expected to increase substantially, causing logistics service providers to contemplate, devise and implement flexible business strategies and operational models to cope up with the future needs.

 
Scope of the Report

The ‘Cold Chain Logistics Market for Healthcare: Focus on Cell Therapies, Vaccines, and Human Organs, 2018-2030’ report features an extensive study of the current landscape and future outlook of the growing cold chain logistics services market. The study features an in-depth analysis, highlighting the capabilities of the various service providers engaged in this domain. Amongst other elements, the report features:

  • An analysis comparing the logistical complexities associated with cell therapies, vaccines and human organs, based on several parameters, such as holding temperatures, delivery time restrictions, handling / transportation requirements, and storage related needs.
  • A detailed assessment of the overall market landscape, featuring a comprehensive list of over 80 players that offer cold chain logistics services for cell therapies, vaccines and human organs, and detailed analyses based on a number of parameters, such as the location of headquarters, size of employee base, type of products (cell therapies, vaccines, human organs, pharmaceutical products, and others), type of services offered (storage, packaging, and transportation), mode of transportation (ground, air, and ocean), holding temperature range (ambient, refrigerated, frozen, and deep frozen / cryogenic), type of packaging methods (dry ice, liquid nitrogen, and gel packs), type of container (active and passive containers), type of end-users (industry players and non-industry players), geographical activity and location of cold chain facilities.
  • An insightful 2X2 representation of the results of a competitiveness analysis of various logistics service providers (segregated into three peer groups based on their employee count (small-sized (1-200 employees), mid-sized (>201-1,000 employees) and large (>1,000 employees)), highlighting capable players in this domain, based on their cold chain logistics capabilities (such as type(s) of container, type(s) of service(s) offered, holding temperature range, modes of transportation employed, geographical activity and type(s) of cold chain product(s)) and supplier power.
  • Elaborate profiles of leading cold chain logistics service providers (shortlisted on the basis of the company competitiveness analysis), featuring an overview of the company, its financial information (if available), funding information (if available), information on cold chain logistics service(s) / product(s), recent partnerships, and a comprehensive future outlook.
  • An analysis of the partnerships that have been established in the recent past, covering service alliances, logistics service agreements, merger / acquisitions, equipment development / manufacturing agreements, R&D agreements, and joint ventures.
  • A detailed discussion on the various regulatory guidelines that have been laid down by major regulatory bodies (such as European Medicines Agency (EMA), United States Food and Drug Administration (USFDA), Health Canada (HC), International Air Transport Association (IATA), International Council for Harmonisation (ICH), International Safe Transit Association (ISTA), Parenteral Drug Association (PDA), United States Pharmacopeia (USP), and World Health Organization (WHO)), specific to cold chain management. In addition, it features an insightful analysis, comparing regulatory authorities based on the guidelines issued by them for different stages of the cold chain.
  • A case study on the cold chain management strategies used for over 190 drugs (both biologics and small molecules)that were approved in the last five years, highlighting year-wise trend of cold chain adoption. In addition, it analyzes the cold chain temperature requirements of these drugs, based on several parameters, including type of molecule(s), dosage form and route of administration.
  • A detailed estimation of the likely demand for logistics services for [A] cell therapies (including stem cell therapies, T-cell therapies, dendritic cell therapies, natural killer cell therapies and tumor therapies), considering the contributions of clinical and commercial stage products over the period 2018-2030; [B] vaccines (including over 15 types of mandatory and optional vaccines), considering the contributions of both clinical and commercially available products for both infants and adults, over the period 2018-2030; and [C] human organs (including heart, intestine, kidney, liver, lung, and pancreas) for transplants, over the period 2018-2030.
  • A discussion on affiliated trends, key drivers and challenges, which are likely to impact the industry’s evolution, under a comprehensive SWOT framework. It also includes a Harvey ball analysis, highlighting the relative effect of each SWOT parameter on the overall cold chain logistics market.
  • A discussion on the upcoming tools / technologies (such as integration of automation and robotics, cloud computing, blockchain technology, artificial intelligence and other such advanced technical solutions) in the field of cold chain logistics and their likely impact on the future evolution of this market.

One of the key objectives of the report was to estimate the existing market size and potential growth opportunities for cold chain logistics over the coming decade. Based on several parameters, we have provided an informed estimate of the likely evolution of this market in the short to mid-term and long term, for the period 2018-2030. In addition, we have provided the likely distribution of the future opportunity based on [A] regional evolution of the market covering key geographies, such as North America (the US, Canada and Mexico), Europe (the UK, Germany, France, Germany, Spain and Italy), Asia-Pacific and Rest of the World (Australia, China, India, and Japan), [B] type of products (cell therapies, vaccines, and human organs), [C] holding temperature ranges (refrigerated, frozen, and cryogenic), [D] type of containers (active and passive containers), and [E] type of end-users (industry players and non-industry players). In order to account for the uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios portraying the conservative, base and optimistic tracks of the industry’s evolution.

The opinions and insights presented in this study were also influenced by discussions conducted with several stakeholders in this domain. The report features detailed transcripts of interviews held with the following individuals:

  • Elena Boykova (Marketing Communications Manager, AirBridgeCargo Airlines)
  • Jacqueline Barry (Chief Clinical Officer, Catapult Cell and Gene Therapy)
  • Michelle Arnot-Kruger (Health Specialist, Cold Chain Logistics, UNICEF)
  • Shehdeh Abusnineh (Supply Chain Manager, Tabuk Pharmaceuticals).

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

Contents

Chapter 2 is an executive summary of the insights captured in our research. It offers a high-level view on the state of the healthcare cold chain logistics market in the short to mid-term and long term.

Chapter 3 is an introductory chapter that provides a detailed comparison of the traditional supply chain and cold chain, along with information on the various processes and procedures associated with cold chain logistics, including a discussion on its historical evolution. It also elaborates on the key steps involved in cold chain logistics operations of temperature-sensitive healthcare products, including cold chain storage, packaging, transportation and monitoring. Further, the chapter provides a brief overview of different kinds of healthcare products, which require cold chain operations, along with the preferred storage / transportation temperature ranges for each product. It also features a comprehensive discussion on the various modes of transportation used for such shipments. Further, the chapter features a discussion on the various advantages and limitations associated with the cold chain logistics and management industry.

Chapter 4 features a detailed discussion on various complexities associated with the cold chain logistics operations for cell therapies, vaccines and human organs. It also highlights the criticality of cold chain logistics during product manufacturing, storage, packaging and transportation. Furthermore, it provides information on recommended cold chain temperature profiles and best practices for shipping and storage of the aforementioned product types. The chapter also elaborates on the various challenges related to cold chain logistics operations and their solutions. It includes two case studies of recent advancements, namely cell orchestration platforms for management of cell therapy logistics and innovative beating heart-in-a-box technology for efficient human organ logistics. It also includes an informative multi-valent analysis to compare the logistical complexities related to cell therapies, vaccines and human organs based on several parameters, such as temperature conditions, delivery time restrictions, handling / transportation requirements, and storage related needs.

Chapter 5 includes a comprehensive market landscape analysis of companies that offer cold chain logistics services, particularly for the shipping of cell therapies, vaccines and human organs. The chapter presents detailed analyses on the basis of the location of their headquarters, employee count, type of products (cell therapies, vaccines, human organs, pharmaceutical products, and others), type of services offered (storage, packaging, and transportation), mode of transportation (ground, air, and ocean), holding temperature range (ambient, refrigerated, frozen, and deep frozen / cryogenic), type of packaging methods (dry ice, liquid nitrogen, and gel packs), type of container (active and passive containers), type of end-users (industry players and non-industry players), geographical activity and location of cold chain facilities. The chapter also provides a list of cold chain equipment / technologies and monitoring systems, along with their developers. Further, it includes an indicative list of players offering cold chain logistics for other pharmaceutical products,and a list of companies that are acting as air ambulances for the transportation of human organs.

Chapter 6 features a comprehensive 2X2 analysis offering a comparative summary of all the cold chain logistics service providers that we came across during our research. The analysis compares the aforementioned companies within three peer-groups, established based on size of employee base (small-sized (1-200 employees), mid-sized (>201-1,000 employees) and large (>1,000 employees)). The companies were compared based on their cold chain logistics capabilities, such as type(s) of container, type(s) of service(s) offered, holding temperature range, modes of transportation employed, geographical activity and type(s) of cold chain product(s) and supplier power.

Chapter 7 provides detailed profiles of some of the important cold chain logistics providers (shortlisted on the basis of the company competitiveness analysis), based in different geographies. Each company profile includes a brief overview of the company, financial information (if available), funding information (if available), details on its cold chain logistics service(s) / product(s) capabilities, recent partnerships, and a comprehensive future outlook.

Chapter 8 features an elaborate discussion and analysis of the various partnerships / collaborations that have been inked amongst players in this market. It includes a brief description on the various types of partnership models (such as service alliances, logistics service agreements, merger / acquisitions, equipment development / manufacturing agreements, R&D agreements, and joint ventures) that have been employed by stakeholders in this domain, and analysis on the trend of partnerships inked since 2014. It also consists of a schematic representation showcasing the service providers that have established the maximum number of alliances. Furthermore, we have provided a world map representation of all the deals inked in this field, highlighting those that have been established within and across different continents. In addition, it includes an analysis of the mergers and acquisitions that have taken place in the last five years. The chapter also highlights the recent facility expansions undertaken by cold chain logistics providers in the given time period.

Chapter 9 provides information on the regulatory guidelines that have been laid down by key regulatory bodies / organizations, specific to cold chain management in the healthcare industry. These include EMA, USFDA, HC, IATA, ICH, ISTA, PDA, USP, and WHO. In addition, it features an insightful analysis, comparing different regulatory authorities, based on the guidelines issued by them for different stages of the cold chain.

Chapter 10 presents a case study on the cold chain management strategies for over 190 drugs (both biologics and small molecules) approved by the USFDA from 2014 to 2018 (till July), highlighting year-wise trend of cold chain adoption. The chapter comprises of in-depth analyses, highlighting the cold chain temperature requirements of these drugs, based on several parameters, including type of molecule(s), dosage form and route of administration. Furthermore, we have also highlighted the leading players in this domain, based on the number of cold chain drug approvals received in the given time period.

Chapter 11 features a holistic view on the demand for cell therapy products (both clinical and commercial stage) in the market, allowing us to present an informed opinion on the required scale of supply (in terms of cold chain logistics support). For the purpose of estimating the current clinical demand, we looked at the active clinical studies that have been registered in the last five years for different types of cell therapy product candidates, including stem cell therapies, T-cell therapies, dendritic cell therapies, natural killer cell therapies and tumor therapies. Further, the data was analyzed on the basis of various parameters, such as number of trials, type of cell therapies, regional distribution, leading industry and non-industry players, key indications, and enrolled patient population across different geographies. In order to estimate the commercial demand, we looked at the currently available and late-stage cell therapies across the aforementioned classes, which are expected to receive approval in the coming decade.

Chapter 12 features a holistic view on the demand for vaccines (both clinical and commercially available) in the market, allowing us to present an informed opinion on the required scale of supply (in terms of cold chain logistics support). For the purpose of estimating the current clinical demand, we looked at the active clinical studies that have been registered in the last five years for different types of vaccines. Further, the data was analyzed on the basis of various parameters, such as number of trials, recommended holding temperature, regional distribution, leading industry and non-industry players, and enrolled patient population across different geographies. In order to estimate the commercial demand, we looked at the commercially available vaccines (both mandatory and optional) that are shipped in different countries across the globe, to be administered to the patients (both infants and adults), over the period 2018-2030.

Chapter 13 features a detailed analysis of the current demand for cold chain logistics for human organs, wherein we considered the actual transplants, patients on the waiting list and available donors for vital human organs (including heart, kidney, liver, lung, and intestine / pancreas), across different geographies.

Chapter 14 features a comprehensive market forecast, highlighting the future potential of cold chain logistics market till 2030. We have segmented the market on the basis of [A] regional evolution of the market covering key geographies, such as North America (the US, Canada and Mexico), Europe (the UK, Germany, France, Germany, Spain and Italy), Asia-Pacific and Rest of the World (Australia, China, India, and Japan), [B] type of products (cell therapies, vaccines, and human organs), [C] holding temperature ranges (refrigerated, frozen, and cryogenic), [D] type of containers (active and passive containers), and [E] type of end-users (industry players and non-industry players).

Chapter 15 provides a detailed analysis capturing the key parameters and trends that are likely to influence the future of cold chain management in the healthcare industry, under a comprehensive SWOT framework.

Chapter 16 provides a discussion on the upcoming tools / technologies, which are being developed / adopted by the cold chain logistics service providers, that are likely to have a notable influence on the industry’s evolution over the coming decade. These include (but not limited to) integration of automation and robotics, augmented reality, cloud computing, internet of things (IoT), radio frequency identification (RFID), blockchain technology, artificial intelligence and big data analytics. In addition,the chapter presents an exemplary list of players that are offering the aforementioned technologies for cold chain logistics to the healthcare and pharmaceutical industry. It also features a qualitative Harvey ball analysis to project their adoption in cold chain industry in the short and long term.

Chapter 17 is a collection of executive insights of the discussions that were held with key stakeholders in this market. The chapter provides a brief overview of the companies and details of interviews held with Elena Boykova (Marketing Communications Manager, AirBridgeCargo Airlines), Jacqueline Barry (Chief Clinical Officer, Catapult Cell and Gene Therapy), Michelle Arnot-Kruger (Health Specialist, Cold Chain Logistics, UNICEF), and Shehdeh Abusnineh (Supply Chain Manager, Tabuk Pharmaceuticals).

Chapter 18 is an appendix, which provides tabulated data and numbers for all the figures provided in the report.

Chapter 19 is an appendix, which contains the list of companies and organizations mentioned in the report.

Table of Contents

1 PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines

2 EXECUTIVE SUMMARY
 

 
3. INTRODUCTION
3.1. Chapter Overview
3.2. Concept of Cold Chain Logistics
3.2.1. Comparison of Conventional Supply Chain and Cold Chain
3.2.2. Historical Evolution of the Cold Chain Logistics Industry
 
3.3. Cold Chain Logistics in Healthcare
3.4. Types of Healthcare Products Requiring Cold Chain Logistics
 
3.5. Types of Container used in Cold Chain Logistics
3.5.1. Active Cold Chain Containers
3.5.2. Passive Cold Chain Containers
3.5.3. Insulated Cold Chain Containers
 
3.6. Modes of Transportation
3.6.1. Road Transportation
3.6.2. Air Transportation
3.6.3. Ocean / Marine Transportation
3.6.4. Rail Transportation
3.6.5. Intermodal and Multimodal Transportation
3.6.6. Comparison of Modes of Transportation
 
3.7. Advantages and Limitations of Cold Chain Logistics in Healthcare
3.8. Concluding Remarks
 
4. COLD CHAIN LOGISTICS FOR CELL THERAPIES, VACCINES AND HUMAN ORGANS
4.1. Chapter Overview
4.2. Cold Chain Management for Cell Therapies
4.2.1. An Introduction to Cell Therapies
4.2.2. Classification of Cell Therapies
 
4.2.3. An Overview of Cell Therapy Logistics
4.2.3.1. Cold Chain Logistics for Autologous Cell Therapies
4.2.3.2. Cold Chain Logistics for Allogeneic Cell Therapies
4.2.3.3. Comparison of Cold Chain Logistics for Autologous and Allogenic Cell Therapies
 
4.2.4. Cold Storage of Cell Therapies
4.2.5. Challenges Related to Cell Therapy Logistics
4.2.5.1. Process Standardization
4.2.5.2. Packaging and Shipping Qualifications
4.2.5.3. Validation of Storage Containers
4.2.5.4. Logistical Process Qualification
4.2.5.5. Chain-of-Custody Documentation
4.2.6. Strategies to Overcome Existing Challenges in Cell Therapy Logistics
4.2.7. Case-in-Point: Cell Orchestration Platforms for Management of Cell Therapy Logistics
 
4.3. Cold Chain Management for Vaccines
4.3.1. An Introduction to Vaccines
4.3.2. Classification of Vaccines
4.3.3. An Overview of Vaccine Logistics
4.3.4. Cold Storage of Vaccines
 
4.3.5. Challenges Related to Vaccine Logistics
4.3.5.1. Heat Sensitivity
4.3.5.2. Cross-Border Shipments
4.3.5.3. Choice of Suitable Containers
 
4.4. Cold Chain Management for Human Organs
4.4.1. An Introduction to Human Organ Transplantation
4.4.2. An Overview of Human Organ Logistics
4.4.3. Storage / Preservation of Human Organs
 
4.4.4. Challenges Related to Human Organ Logistics
4.4.4.1. Organ Matching
4.4.4.2. Organ Viability
4.4.4.3. Organ Packaging, Labelling and Transportation
4.4.5. Case-in-Point: Beating Heart-in-a-Box
 
4.5. Logistical Complexity Analysis for Different Products
 
5. MARKET LANDSCAPE
5.1. Chapter Overview
5.2. Cold Chain Logistics Service Providers: List of Industry Players
5.2.1. Analysis by Year of Establishment
5.2.2. Analysis by Location of Headquarters
5.2.3. Analysis by Size of Company
5.2.4. Analysis by Type of Products
5.2.5. Analysis by Type of Cold Chain Logistics Service(s)
5.2.6. Analysis by Mode of Transportation
5.2.7. Analysis by Holding Temperature Range
5.2.8. Analysis by Type of Containers
5.2.9. Analysis by Type of End-Users
5.2.10. Analysis by Geographical Activity
5.2.11. Analysis by Location of Cold Chain Facility
 
5.3. List of Cold Chain Logistics Service Providers for Other Healthcare Products
5.4. List of Equipment / Technologies for Cold Chain Logistics
 
6. COMPANY COMPETITIVENESS ANALYSIS
6.1. Chapter Overview
6.2. Methodology
6.3. Assumptions and Key Parameters
6.4. Cold Chain Logistics Service Providers: Competitive Landscape
6.4.1. Small-sized Companies
6.4.2. Mid-sized Companies
6.4.3. Large Companies
 
7. COMPANY PROFILES
7.1. Chapter Overview
 
7.2. Cryoport
7.2.1. Company Snapshot
7.2.2. Financial Information
7.2.3. Cold Chain Logistics Services / Products
7.2.4. Recent Partnerships
7.2.5. Future Outlook
 
7.3. Lynden International Logistics
7.3.1. Company Snapshot
7.32. Cold Chain Logistics Services / Products
7.3.3. Future Outlook
 
7.4. PAREXEL
7.4.1. Company Snapshot
7.4.2. Financial Information
7.4.3. Cold Chain Logistics Services / Products
7.4.4. Future Outlook
 
7.5. DHL Express
7.5.1. Company Snapshot
7.5.2. Financial Information
7.5.3. Cold Chain Logistics Services / Products
7.5.4. Recent Partnerships
7.5.5. Future Outlook
 
7.6. United Parcel Service
7.6.1. Company Snapshot
7.6.2. Financial Information
7.6.3. Cold Chain Logistics Services / Products
7.6.4. Recent Partnerships
7.6.5. Future Outlook
 
7.7. GAC
7.7.1. Company Snapshot
7.7.2. Cold Chain Logistics Services / Products
7.7.3. Future Outlook
 
7.8. Yusen Logistics
7.8.1. Company Snapshot
7.8.2. Financial Information
7.8.3. Cold Chain Logistics Services / Products
7.8.4. Recent Partnerships
7.8.5. Future Outlook
 
8. RECENT PARTNERSHIPS AND EXPANSIONS
8.1. Chapter Overview
8.2. Partnership Models
8.3. Cold Chain Logistics in Healthcare: List of Partnerships and Collaborations
8.3.1. Analysis by Year of Partnership
8.3.2. Analysis by Type of Partnership
8.3.3. Analysis by Type of Product
8.3.4. Analysis by Type of Cold Chain Logistics Service
8.3.5. Analysis by Type of Cold Chain Logistics Service and Type of Product
8.3.6. Most Active Players: Analysis by Number of Partnerships
8.3.7. Regional Analysis
8.3.7.1. Intercontinental and Intracontinental Agreements
 
8.4. Cold Chain Logistics in Healthcare: Mergers and Acquisitions
8.4.1. Year-Wise Trend
8.4.2. Most Active Acquirers: Analysis by Number of Acquisitions
8.5. Cold Chain Logistics in Healthcare: Recent Expansions
 
9. REGULATORY RECOMMENDATIONS AND GUIDELINES
9.1. Chapter Overview
9.2. Regulatory Guidelines Issued by International Authorities
9.2.1. World Health Organization (WHO)
9.2.2. International Air Transport Association (IATA)
9.2.3. International Committee on Harmonisation (ICH)
9.2.4. International Safe Transit Association (ISTA)
9.2.5. Parenteral Drug Association (PDA)
 
9.3. Regulatory Guidelines for Cold Chain Management in the US
9.3.1. United States Food and Drug Administration (USFDA)
9.3.2. United States Pharmacopeia (USP)
 
9.4. Regulatory Guidelines for Cold Chain Management in Canada
9.4.1. Health Canada
 
9.5. Regulatory Guidelines for Cold Chain Management in Europe
9.5.1. European Medicine Agency (EMA)
 
9.6. Recommendations for Different Steps of Cold Chain Logistics
9.7. Comparative Analysis of Regulatory Authorities
 
10. CASE STUDY: COLD CHAIN REQUIREMENTS FOR APPROVED DRUGS
10.1. Chapter Overview
10.2. List of USFDA Approved Drugs
10.2.1. Analysis by Year of Approval
10.2.2. Analysis by Type of Molecule
10.2.3. Analysis by Type of Biologic
10.2.4. Analysis by Holding Temperature Range
10.2.5. Analysis by Dosage Form and Holding Temperature Range
10.2.6. Analysis by Route of Administration and Holding Temperature Range
10.2.7. Most Active Players: Analysis by Number of Approved Drugs Requiring Cold Chain
 
11. DEMAND ANALYSIS FOR CELL THERAPIES
11.1. Chapter Overview
11.2. Scope and Methodology
 
11.3. Cell Therapies, Global Clinical Demand: Analysis by Number of Trials
11.3.1. Analysis by Trial Registration Year
11.3.2. Analysis by Type of Cell Therapy
11.3.3. Analysis by Trial Phase
11.3.4. Analysis by Type of Cell Therapy and Trial Phase
11.3.5. Analysis by Therapeutic Indications
11.3.6. Geographical Analysis by Number of Clinical Trials
11.3.7. Geographical Analysis by Type of Cell Therapy and Trial Phase
11.3.8. Analysis by Type of Sponsors / Collaborators
11.3.9. Most Active Players
 
11.4. Cell Therapies, Global Clinical Demand: Analysis by Enrolled Patient Population
11.4.1. Analysis by Type of Cell Therapy
11.4.2. Geographical Analysis by Enrolled Patient Population
11.4.3. Geographical Analysis by Type of Cell Therapy and Trial Phase
 
11.5. Cell Therapies, Global Commercial Demand: Analysis by Expected Number of Product Approvals
11.6. Cell Therapies, Global Commercial Demand: Analysis by Target Patient Population
11.7. Concluding Remarks
 
12. DEMAND ANALYSIS FOR VACCINES
12.1. Chapter Overview
12.2. Scope and Methodology
 
12.3. Vaccines, Global Clinical Demand: Analysis by Number of Trials
12.3.1. Analysis by Trial Registration Year
12.3.2. Analysis by Holding Temperature Range
12.3.3. Analysis by Trial Phase
12.3.4. Analysis by Trial Status
12.3.5. Geographical Analysis by Number of Clinical Trials
12.3.6. Geographical Analysis by Trial Status and Trial Phase
12.3.7. Analysis by Type of Sponsors / Collaborators
12.3.8. Most Active Players
 
12.4. Vaccines, Global Clinical Demand: Analysis by Enrolled Patient Population
12.4.1. Geographical Analysis by Enrolled Patient Population
12.4.2. Geographical Analysis of Enrolled Patient Population by Trial Phase and Holding Temperature Range
 
12.5. Vaccines, Global Commercial Demand: Analysis by Type of Vaccine
12.5.1. Demand for Mandatory Vaccines: Global Scenario
12.5.2. Demand for Mandatory Vaccines: Distribution by Geography
12.5.2.1. Present Demand (2018 Scenario)
12.5.2.2. Estimated Demand in the Short Term (2025 Scenario)
12.5.2.3. Estimated Demand in the Long Term (2030 Scenario)
 
12.5.3. Demand for Optional Vaccines: Global Scenario
12.5.4. Demand for Optional Vaccines: Distribution by Geography
12.5.4.1. Present Demand (2018 Scenario)
12.5.4.2. Estimated Demand in the Short Term (2025 Scenario)
12.5.4.3. Estimated Demand in the Long Term (2030 Scenario)
 
12.6. Vaccines, Global Commercial Demand: Analysis by Number of Patients
12.7. Vaccines, Global Commercial Demand: Analysis by Number of Doses
12.8. Concluding Remarks
 
13. DEMAND ANALYSIS FOR HUMAN ORGANS
13.1. Chapter Overview
13.2. Scope and Methodology
 
13.3. Human Organs, Global Demand: Distribution by Geography
13.3.1. Present Demand (2018 Scenario)
13.3.2. Estimated Demand in the Short Term (2025 Scenario)
13.3.3. Estimated Demand in the Long Term (2030 Scenario)
13.3. Human Organs, Global Demand: Analysis by Type of Organ
13.3.1. Kidney
13.3.2. Liver
13.3.3. Heart
13.3.4. Lung
13.3.5. Pancreas and Intestine
 
13.4. Human Organs, Overall Global Demand
13.5. Concluding Remarks
 
14. MARKET FORECAST
14.1. Chapter Overview
14.2. Forecast Methodology and Key Assumptions
14.3. Global Cold Chain Logistics Market, 2018-2030
 
14.4. Global Cold Chain Logistics Market: Distribution by Type of Product
14.4.1. Cold Chain Logistics Market for Cell Therapies, 2018-2030
14.4.2. Cold Chain Logistics Market for Vaccines, 2018-2030
14.4.3. Cold Chain Logistics Market for Human Organs, 2018-2030
 
14.5. Global Cold Chain Logistics Market: Distribution by Holding Temperature Range
14.5.1. Cold Chain Logistics Market for Products Requiring Refrigerated Temperature, 2018-2030
14.5.2. Cold Chain Logistics Market for Products Requiring Frozen Temperature, 2018-2030
14.5.3. Cold Chain Logistics Market for Products Requiring Cryogenic Temperature, 2018-2030
 
14.6. Global Cold Chain Logistics Market: Distribution by Type of Container
14.6.1. Cold Chain Logistics Market for Active Containers, 2018-2030
14.6.2. Cold Chain Logistics Market for Passive Containers, 2018-2030
 
14.7. Global Cold Chain Logistics Market: Distribution by Type of End-User
14.7.1. Cold Chain Logistics Market for Industry Players, 2018-2030
14.7.2. Cold Chain Logistics Market for Non-Industry Players, 2018-2030
 
14.8. Global Cold Chain Logistics Market: Distribution by Geography
14.8.1. Cold Chain Logistics Market in North America, 2018-2030
14.8.1.1. Cold Chain Logistics Market in the US, 2018-2030
14.8.1.2. Cold Chain Logistics Market in Canada, 2018-2030
14.8.1.3. Cold Chain Logistics Market in Mexico, 2018-2030
 
14.8.2. Cold Chain Logistics Market in Europe, 2018-2030
14.8.2.1. Cold Chain Logistics Market in the UK, 2018-2030
14.8.2.2. Cold Chain Logistics Market in Germany, 2018-2030
14.8.2.3. Cold Chain Logistics Market in France, 2018-2030
14.8.2.4. Cold Chain Logistics Market in Spain, 2018-2030
14.8.2.5. Cold Chain Logistics Market in Italy, 2018-2030
14.8.2.6. Cold Chain Logistics Market in Rest of Europe, 2018-2030
 
14.8.3. Cold Chain Logistics Market in Asia-Pacific and Rest of the World, 2018-2030
14.8.3.1. Cold Chain Logistics Market in Australia, 2018-2030
14.8.3.2. Cold Chain Logistics Market in China, 2018-2030
14.8.3.3. Cold Chain Logistics Market in Japan, 2018-2030
14.8.3.4. Cold Chain Logistics Market in India, 2018-2030
14.8.3.5. Cold Chain Logistics Market in Rest of the World, 2018-2030
 
14.9. Global Cold Chain Logistics Market: Distribution by Type of Product and Geography
14.9.1. Cold Chain Logistics Market for Cell Therapies in North America
14.9.1.1. Cold Chain Logistics Market for Cell Therapies in the US, 2018-2030
14.9.1.2. Cold Chain Logistics Market for Cell Therapies in Canada, 2018-2030
14.9.1.3. Cold Chain Logistics Market for Cell Therapies in Mexico, 2018-2030
 
14.9.2. Cold Chain Logistics Market for Cell Therapies in Europe, 2018-2030
14.9.2.1. Cold Chain Logistics Market for Cell Therapies in the UK, 2018-2030
14.9.2.2. Cold Chain Logistics Market for Cell Therapies in Germany, 2018-2030
14.9.2.3. Cold Chain Logistics Market for Cell Therapies in France, 2018-2030
14.9.2.4. Cold Chain Logistics Market for Cell Therapies in Spain, 2018-2030
14.9.2.5. Cold Chain Logistics Market for Cell Therapies in Italy, 2018-2030
14.9.2.6. Cold Chain Logistics Market for Cell Therapies in Rest of Europe, 2018-2030
 
14.9.3. Cold Chain Logistics Market for Cell Therapies in Asia-Pacific and Rest of the World, 2018-2030
14.9.3.1. Cold Chain Logistics Market for Cell Therapies in Australia, 2018-2030
14.9.3.2. Cold Chain Logistics Market for Cell Therapies in China, 2018-2030
14.9.3.3. Cold Chain Logistics Market for Cell Therapies in Japan, 2018-2030
14.9.3.4. Cold Chain Logistics Market for Cell Therapies in India, 2018-2030
14.9.3.5. Cold Chain Logistics Market for Cell Therapies in Rest of the World, 2018-2030
 
14.9.4 Cold Chain Logistics Market for Vaccines in North America
14.9.4.1. Cold Chain Logistics Market for Vaccines in the US, 2018-2030
14.9.4.2. Cold Chain Logistics Market for Vaccines in Canada, 2018-2030
14.9.4.3. Cold Chain Logistics Market for Vaccines in Mexico, 2018-2030
 
14.9.5. Cold Chain Logistics Market for Vaccines in Europe, 2018-2030
14.9.5.1. Cold Chain Logistics Market for Vaccines in the UK, 2018-2030
14.9.5.2. Cold Chain Logistics Market for Vaccines in Germany, 2018-2030
14.9.5.3. Cold Chain Logistics Market for Vaccines in France, 2018-2030
14.9.5.4. Cold Chain Logistics Market for Vaccines in Spain, 2018-2030
14.9.5.5. Cold Chain Logistics Market for Vaccines in Italy, 2018-2030
14.9.5.6. Cold Chain Logistics Market for Vaccines in Rest of Europe, 2018-2030
 
14.9.6. Cold Chain Logistics Market for Vaccines in Asia-Pacific and Rest of the World, 2018-2030
14.9.6.1. Cold Chain Logistics Market for Vaccines in Australia, 2018-2030
14.9.6.2. Cold Chain Logistics Market for Vaccines in China, 2018-2030
14.9.6.3. Cold Chain Logistics Market for Vaccines in Japan, 2018-2030
14.9.6.4. Cold Chain Logistics Market for Vaccines in India, 2018-2030
14.9.6.5. Cold Chain Logistics Market for Vaccines in Rest of the World, 2018-2030
14.9.7. Cold Chain Logistics Market for Human Organs in North America
14.9.7.1. Cold Chain Logistics Market for Human Organs in the US, 2018-2030
14.9.7.2. Cold Chain Logistics Market for Human Organs in Canada, 2018-2030
14.9.7.3. Cold Chain Logistics Market for Human Organs in Mexico, 2018-2030
14.9.8. Cold Chain Logistics Market for Human Organs in Europe, 2018-2030
14.9.8.1. Cold Chain Logistics Market for Human Organs in the UK, 2018-2030
14.9.8.2. Cold Chain Logistics Market for Human Organs in Germany, 2018-2030
14.9.8.3. Cold Chain Logistics Market for Human Organs in France, 2018-2030
14.9.8.4. Cold Chain Logistics Market for Human Organs in Spain, 2018-2030
14.9.8.5. Cold Chain Logistics Market for Human Organs in Italy, 2018-2030
14.9.8.6. Cold Chain Logistics Market for Human Organs in Rest of Europe, 2018-2030
 
14.9.9. Cold Chain Logistics Market for Human Organs in Asia-Pacific and Rest of the World, 2018-2030
14.9.9.1. Cold Chain Logistics Market for Human Organs in Australia, 2018-2030
14.9.9.2. Cold Chain Logistics Market for Human Organs in China, 2018-2030
14.9.9.3. Cold Chain Logistics Market for Human Organs in Japan, 2018-2030
14.9.9.4. Cold Chain Logistics Market for Human Organs in India, 2018-2030
14.9.9.5. Cold Chain Logistics Market for Human Organs in Rest of the World, 2018-2030
 
14.10. Global Cold Chain Logistics Market: Distribution by Holding Temperature Range and Geography
14.10.1. Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in North America
14.10.1.1. Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in the US, 2018-2030
14.10.1.2. Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Canada, 2018-2030
14.10.1.3. Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Mexico, 2018-2030
 
14.10.2. Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Europe, 2018-2030
14.10.2.1. Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in the UK, 2018-2030
14.10.2.2. Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Germany, 2018-2030
14.10.2.3. Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in France, 2018-2030
14.10.2.4. Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Spain, 2018-2030
14.10.2.5. Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Italy, 2018-2030
14.10.2.6. Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Rest of Europe, 2018-2030
 
14.10.3. Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Asia-Pacific and Rest of the World, 2018-2030
14.10.3.1. Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Australia, 2018-2030
14.10.3.2. Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in China, 2018-2030
14.10.3.3. Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Japan, 2018-2030
14.10.3.4. Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in India, 2018-2030
14.10.3.5. Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Rest of the World, 2018-2030
 
14.10.4. Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in North America
14.10.4.1. Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in the US, 2018-2030
14.10.4.2. Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Canada, 2018-2030
14.10.4.3. Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Mexico, 2018-2030
 
14.10.5. Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Europe, 2018-2030
14.10.5.1. Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in the UK, 2018-2030
14.10.5.2. Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Germany, 2018-2030
14.10.5.3. Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in France, 2018-2030
14.10.5.4. Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Spain, 2018-2030
14.10.5.5. Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Italy, 2018-2030
14.10.5.6. Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Rest of Europe, 2018-2030
 
14.10.6. Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Asia-Pacific and Rest of the World, 2018-2030
14.10.6.1. Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Australia, 2018-2030
14.10.6.2. Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in China, 2018-2030
14.10.6.3. Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Japan, 2018-2030
14.10.6.4. Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in India, 2018-2030
14.10.6.5. Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Rest of the World, 2018-2030
 
14.11. Global Cold Chain Logistics Market: Distribution by Type of Container and Geography
14.11.1. Cold Chain Logistics Market for Active Containers in North America
14.11.1.1. Cold Chain Logistics Market for Active Containers in the US, 2018-2030
14.11.1.2. Cold Chain Logistics Market for Active Containers in Canada, 2018-2030
14.11.1.3. Cold Chain Logistics Market for Active Containers in Mexico, 2018-2030
 
14.11.2. Cold Chain Logistics Market for Active Containers in Europe, 2018-2030
14.11.2.1. Cold Chain Logistics Market for Active Containers in the UK, 2018-2030
14.11.2.2. Cold Chain Logistics Market for Active Containers in Germany, 2018-2030
14.11.2.3. Cold Chain Logistics Market for Active Containers in France, 2018-2030
14.11.2.4. Cold Chain Logistics Market for Active Containers in Spain, 2018-2030
14.11.2.5. Cold Chain Logistics Market for Active Containers in Italy, 2018-2030
14.11.2.6. Cold Chain Logistics Market for Active Containers in Rest of Europe, 2018-2030
 
14.11.3. Cold Chain Logistics Market for Active Containers in Asia-Pacific and Rest of the World, 2018-2030
14.11.3.1. Cold Chain Logistics Market for Active Containers in Australia, 2018-2030
14.11.3.2. Cold Chain Logistics Market for Active Containers in China, 2018-2030
14.11.3.3. Cold Chain Logistics Market for Active Containers in Japan, 2018-2030
14.11.3.4. Cold Chain Logistics Market for Active Containers in India, 2018-2030
14.11.3.5. Cold Chain Logistics Market for Active Containers in Rest of the World, 2018-2030
 
14.11.4. Cold Chain Logistics Market for Passive Containers in North America
14.11.4.1. Cold Chain Logistics Market for Passive Containers in the US, 2018-2030
14.11.4.2. Cold Chain Logistics Market for Passive Containers in Canada, 2018-2030
14.11.4.3. Cold Chain Logistics Market for Passive Containers in Mexico, 2018-2030
 
14.11.5. Cold Chain Logistics Market for Passive Containers in Europe, 2018-2030
14.11.5.1. Cold Chain Logistics Market for Passive Containers in the UK, 2018-2030
14.11.5.2. Cold Chain Logistics Market for Passive Containers in Germany, 2018-2030
14.11.5.3. Cold Chain Logistics Market for Passive Containers in France, 2018-2030
14.11.5.4. Cold Chain Logistics Market for Passive Containers in Spain, 2018-2030
14.11.5.5. Cold Chain Logistics Market for Passive Containers in Italy, 2018-2030
14.11.5.6. Cold Chain Logistics Market for Passive Containers in Rest of Europe, 2018-2030
 
14.11.6. Cold Chain Logistics Market for Passive Containers in Asia-Pacific and Rest of the World, 2018-2030
14.11.6.1. Cold Chain Logistics Market for Passive Containers in Australia, 2018-2030
14.11.6.2. Cold Chain Logistics Market for Passive Containers in China, 2018-2030
14.11.6.3. Cold Chain Logistics Market for Passive Containers in Japan, 2018-2030
14.11.6.4. Cold Chain Logistics Market for Passive Containers in India, 2018-2030
14.11.6.5. Cold Chain Logistics Market for Passive Containers in Rest of the World, 2018-2030
 
14.12. Global Cold Chain Logistics Market: Distribution by Type of End-User and Geography
14.12.1. Cold Chain Logistics Market for Industry Players in North America
14.12.1.1. Cold Chain Logistics Market for Industry Players in the US, 2018-2030
14.12.1.2. Cold Chain Logistics Market for Industry Players in Canada, 2018-2030
14.12.1.3. Cold Chain Logistics Market for Industry Players in Mexico, 2018-2030
 
14.12.2. Cold Chain Logistics Market for Industry Players in Europe, 2018-2030
14.12.2.1. Cold Chain Logistics Market for Industry Players in the UK, 2018-2030
14.12.2.2. Cold Chain Logistics Market for Industry Players in Germany, 2018-2030
14.12.2.3. Cold Chain Logistics Market for Industry Players in France, 2018-2030
14.12.2.4. Cold Chain Logistics Market for Industry Players in Spain, 2018-2030
14.12.2.5. Cold Chain Logistics Market for Industry Players in Italy, 2018-2030
14.12.2.6. Cold Chain Logistics Market for Industry Players in Rest of Europe, 2018-2030
 
14.12.3. Cold Chain Logistics Market for Industry Players in Asia-Pacific and Rest of the World, 2018-2030
14.12.3.1. Cold Chain Logistics Market for Industry Players in Australia, 2018-2030
14.12.3.2. Cold Chain Logistics Market for Industry Players in China, 2018-2030
14.12.3.3. Cold Chain Logistics Market for Industry Players in Japan, 2018-2030
14.12.3.4. Cold Chain Logistics Market for Industry Players in India, 2018-2030
14.12.3.5. Cold Chain Logistics Market for Industry Players in Rest of the World, 2018-2030
 
14.12.4. Cold Chain Logistics Market for Non-Industry Players in North America
14.12.4.1. Cold Chain Logistics Market for Non-Industry Players in the US, 2018-2030
14.12.4.2. Cold Chain Logistics Market for Non-Industry Players in Canada, 2018-2030
14.12.4.3. Cold Chain Logistics Market for Non-Industry Players in Mexico, 2018-2030
 
14.12.5. Cold Chain Logistics Market for Non-Industry Players in Europe, 2018-2030
14.12.5.1. Cold Chain Logistics Market for Non-Industry Players in the UK, 2018-2030
14.12.5.2. Cold Chain Logistics Market for Non-Industry Players in Germany, 2018-2030
14.12.5.3. Cold Chain Logistics Market for Non-Industry Players in France, 2018-2030
14.12.5.4. Cold Chain Logistics Market for Non-Industry Players in Spain, 2018-2030
14.12.5.5. Cold Chain Logistics Market for Non-Industry Players in Italy, 2018-2030
14.12.5.6. Cold Chain Logistics Market for Non-Industry Players in Rest of Europe, 2018-2030
 
14.12.6. Cold Chain Logistics Market for Non-Industry Players in Asia-Pacific and Rest of the World, 2018-2030
14.12.6.1. Cold Chain Logistics Market for Non-Industry Players in Australia, 2018-2030
14.12.6.2. Cold Chain Logistics Market for Non-Industry Players in China, 2018-2030
14.12.6.3. Cold Chain Logistics Market for Non-Industry Players in Japan, 2018-2030
14.12.6.4. Cold Chain Logistics Market for Non-Industry Players in India, 2018-2030
14.12.6.5. Cold Chain Logistics Market for Non-Industry Players in Rest of the World, 2018-2030
 
14.13. Global Cold Chain Logistics Market: Distribution by Type of Product and End-Users
14.13.1. Cold Chain Logistics Market for Cell Therapies for Industry Players
14.13.2. Cold Chain Logistics Market for Cell Therapies for Non-Industry Players
14.13.3. Cold Chain Logistics Market for Vaccines for Industry Players
14.13.4. Cold Chain Logistics Market for Vaccines for Non-Industry Players
14.13.5. Cold Chain Logistics Market for Human Organs for Non-Industry Players
 
14.14. Concluding Remarks
 
15. SWOT ANALYSIS
15.1. Chapter Overview
15.2. Strengths
15.3. Weakness
15.4. Opportunities
15.5. Threats
15.6. Comparison of SWOT Factors
 
16. UPCOMING TRENDS AND FUTURE GROWTH OPPORTUNITIES
16.1. Chapter Overview
16.2. Connected Cold Chain: Key Tools And Technologies
16.2.1. Artificial Intelligence
16.2.2. Augmented Reality
16.2.3. Automation and Robotics
16.2.4. Big Data Analytics
16.2.5. Blockchain Technology
16.2.6. Cloud Computing
16.2.7. Internet of Things
16.2.8. Radio Frequency Identification (RFID) Tags
 
16.3. Connected Cold Chain: Future Growth Opportunities
 
16.4. Real-Time Monitoring: An Application of Connected Cold Chain Solutions
16.4.1. Methods for Integration of Real-Time Monitoring in Cold Chain Logistics
16.4.1.1. RFID Based Real-Time Monitoring
16.4.1.2. Blockchain and IoT Based Real-Time Monitoring
16.4.2. Growth Opportunities for Real-Time Monitoring in Connected Cold Chain
16.4.3. Cost Benefits of Real-Time Monitoring in Cold Chain Logistics
 
17. EXECUTIVE INSIGHTS
17.1. Chapter Overview
 
17.2. AirBridgeCargo Airlines
17.2.1. Company Snapshot
17.2.2. Interview Transcript: Elena Boykova, Marketing Communications Manager
 
17.3. Cell and Gene Therapy Catapult
17.3.1. Company Snapshot
17.3.2. Interview Transcript: Jacqueline Barry, Chief Clinical Officer
 
17.4. UNICEF
17.4.1. Company Snapshot
17.4.2. Interview Transcript: Michelle Arnot-Kruger, Health Specialist, Cold Chain Logistics
 
17.5. Tabuk Pharmaceuticals
17.5.1. Company Snapshot
17.5.2. Interview Transcript: Shehdeh Abusnineh, Supply Chain Manager
 
18. APPENDIX 1: TABULATED DATA
 
19. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
 
List of Figures
Figure 3.1 Key Steps Involved in Supply Chain
Figure 3.2 Differences between Conventional Supply Chain and Cold Chain
Figure 3.3 Key Milestones in Cold Chain Logistics Industry
Figure 3.4 Applications of Cold Chain Logistics
Figure 3.5 Key Components of Cold Chain Logistics Process
Figure 3.6 Types of Healthcare Products requiring Cold Chain Logistics
Figure 3.7 Recommended Holding Temperature Ranges for Various Healthcare Products
Figure 3.8 Types of Active Cold Chain Containers
Figure 3.9 Types of Materials / Methods used in Passive Cold Chain Containers
Figure 3.10 Types of Insulated Cold Chain Containers
Figure 3.11 Key Considerations for Management of Road Shipments
Figure 3.12 Key Considerations for Management of Road Shipments using Passive Cold Chain Containers
Figure 3.13 Types of Carriers for Air Transportation
Figure 3.14 Key Considerations for Management of Air Shipments
Figure 3.15 Advantages and Limitations of Cold Chain Logistics in Healthcare
Figure 4.1 Key Steps Involved in Cell Therapy Manufacturing and Logistics
Figure 4.2 Key Steps Involved in Autologous Cell Therapy Logistics
Figure 4.3 Comparison of Cold Chain Logistics Processes for Autologous and Allogeneic Cell Therapies
Figure 4.4 Key Considerations for Storage of Cell Therapies
Figure 4.5 Key Challenges Related to Cell Therapy Logistics
Figure 4.6 Key Considerations for Transportation of Cell Therapies
Figure 4.7 Temperature Variations across Cryogenic Vessel / Dewar for Storage of Cell Therapies
Figure 4.8 Conditional Recommendations for Process Qualifications for Cell Therapies
Figure 4.9 Cell Therapy Logistics Roadmap for the US
Figure 4.1 Advantages of Cellular Orchestration Platforms
Figure 4.11 Key Steps in Vaccine Transportation Process
Figure 4.12 Key Considerations for Storage of Vaccines
Figure 4.13 Heat Sensitivity of Different Types of Vaccines
Figure 4.14 Types of Containers for Transportation of Vaccines
Figure 4.15 Key Considerations for Storage of Human Organs
Figure 4.16 Conventional Methods for Preservation of Human Organs
Figure 4.17 Recommended Storage Time Period for Different Human Organs for Maintaining Viability
Figure 4.18 Key Considerations for Organ Packaging, Labelling and Transportation
Figure 4.19 Logistical Process for Heart-in-a-Box Device
Figure 5.1 Cold Chain Logistics Service Providers: Distribution by Year of Establishment
Figure 5.2 Cold Chain Logistics Service Providers: Distribution by Location of Headquarters
Figure 5.3 Cold Chain Logistics Service Providers: Distribution by Size of Company
Figure 5.4 Cold Chain Logistics Service Providers: Distribution by Size of Company and Geographical Location
Figure 5.5 Cold Chain Logistics Service Providers: Distribution by Type of Products
Figure 5.6 Cold Chain Logistics Service Providers: Distribution by Type of Cold Chain Logistics Services
Figure 5.7 Cold Chain Logistics Service Providers: Distribution by Mode of Transportation
Figure 5.8 Cold Chain Logistics Service Providers: Distribution by Holding Temperature Range
Figure 5.9 Cold Chain Logistics Service Providers: Distribution by Type of Container
Figure 5.10 Cold Chain Logistics Service Providers: Distribution by Type of End-User
Figure 5.11 Cold Chain Logistics Service Providers: Distribution by Geographical Activity
Figure 5.12 Cold Chain Logistics Service Providers: Distribution by Location of Cold Chain Facility (North America)
Figure 5.13 Cold Chain Logistics Service Providers: Distribution by Location of Cold Chain Facility (Europe)
Figure 5.14 Cold Chain Logistics Service Providers: Distribution by Location of Cold Chain Facility (Asia-Pacific and Rest of the World)
Figure 6.1 Company Competitiveness Analysis: Assumptions and Key Parameters
Figure 6.2 Company Competitiveness Analysis: Dot-Plot Representation (Small-sized Players)
Figure 6.3 Company Competitiveness Analysis: Dot-Plot Representation (Mid-sized Players)
Figure 6.4 Company Competitiveness Analysis: Dot-Plot Representation (Large Players)
Figure 7.1 Cryoport: Annual Revenues, 2014-H1 2018 (USD Million)
Figure 7.2 Cryoport: Cold Chain Logistics Services / Products
Figure 7.3 Lynden International Logistics: Cold Chain Logistics Services / Products
Figure 7.4 PAREXEL: Annual Revenues, 2014-2017 (USD Million)
Figure 7.5 PAREXEL: Cold Chain Logistics Services / Products
Figure 7.6 DHL Express: Annual Revenues, 2014-H1 2018 (EUR Million)
Figure 7.7 DHL Express: Cold Chain Logistics Services / Products
Figure 7.8 United Parcel Service: Annual Revenues, 2014-H1 2018 (USD Million)
Figure 7.9 United Parcel Service: Cold Chain Logistics Services / Products
Figure 7.10 GAC: Cold Chain Logistics Services / Products
Figure 7.11 Yusen Logistics: Annual Revenues, 2014-H1 2018 (JPY Million)
Figure 7.12 Yusen Logistics: Cold Chain Logistics Services / Products
Figure 8.1 Partnerships and Collaborations: Cumulative Trend by Year (2014-2018)
Figure 8.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 8.3 Partnerships and Collaborations: Cumulative Trend by Type of Partnership and Year (2014-2018)
Figure 8.4 Partnerships and Collaborations: Distribution by Type of Product
Figure 8.5 Partnerships and Collaborations: Distribution by Type of Cold Chain Logistics Service
Figure 8.6 Partnerships and Collaborations: Cumulative Trend by Type of Cold Chain Logistics Service (2014-2018)
Figure 8.7 Partnerships and Collaborations: Heat Map Analysis by Type of Cold Chain Logistics Service and Type of Product
Figure 8.8 Partnerships and Collaborations: Most Active Players
Figure 8.9 Partnerships and Collaborations: Regional Distribution
Figure 8.10 Partnerships and Collaborations: Intercontinental and Intracontinental Distribution
Figure 8.11 Mergers and Acquisitions: Year-Wise Trend (2014-2018)
Figure 8.12 Mergers and Acquisitions: Most Active Acquirers
Figure 8.13 Recent Expansions: Capacity Additions (2016-2018)
Figure 9.1 Cold Chain Logistics in Healthcare: International and Regional Regulatory Authorities
Figure 9.2 WHO Guidelines for Cold Chain Logistics
Figure 9.3 IATA (CEIV Pharma) Guidelines for Cold Chain Logistics
Figure 9.4 ICH Guidelines for Cold Chain Logistics
Figure 9.5 ISTA Guidelines for Cold Chain Logistics
Figure 9.6 PDA Guidelines for Cold Chain Logistics
Figure 9.7 USFDA Guidelines for Cold Chain Logistics
Figure 9.8 USFDA Form483s Excerpts: Challenges and Solutions Related to Cold Chain Logistics
Figure 9.9 USP Guidelines for Cold Chain Logistics
Figure 9.10 EMA Guidelines for Cold Chain Logistics
Figure 9.11 Regulatory Requirements for Various Steps of Cold Chain Logistics
Figure 9.12 Comparative Analysis of Regulatory Authorities
Figure 10.1 Cold Chain Requirements for Approved Drugs (2014-2018): Analysis by Year of Approval
Figure 10.2 Cold Chain Requirements for Approved Drugs (2014-2018): Analysis by Type of Molecule and Holding Temperature
Figure 10.3 Cold Chain Requirements for Approved Biologics (2014-2018): Analysis by Type of Biologic
Figure 10.4 Cold Chain Requirements for Approved Drugs (2014-2018): Heat Map Analysis by Holding Temperature Ranges
Figure 10.5 Cold Chain Requirements for Approved Drugs (2014-2018): Analysis by Dosage Form and Holding Temperature
Figure 10.6 Cold Chain Requirements for Approved Drugs (2014-2018): Analysis by Route of Administration and Holding Temperature
Figure 10.7 Cold Chain Requirements for Approved Drugs (2014-2018): Most Active Players
Figure 11.1 Cell Therapies, Global Clinical Demand Analysis: Cumulative Distribution of Trials by Registration Year
Figure 11.2 Cell Therapies, Global Clinical Demand Analysis: Distribution of Trials by Type of Cell Therapy
Figure 11.3 Cell Therapies, Global Clinical Demand Analysis: Distribution of Trials by Phase
Figure 11.4 Cell Therapies, Global Clinical Demand Analysis: Distribution of Trials by Type of Cell Therapy and Trial Phase
Figure 11.5 Cell Therapies, Global Clinical Demand Analysis: Distribution of Trials by Therapeutic Indications
Figure 11.6 Cell Therapies, Global Clinical Demand Analysis: Geographical Distribution of Trials (Country-Wise)
Figure 11.7 Cell Therapies, Global Clinical Demand Analysis: Geographical Distribution of Trials by Type of Cell Therapy and Trial Phase
Figure 11.8 Cell Therapies, Global Clinical Demand Analysis: Distribution of Trials by Type of Sponsors / Collaborators
Figure 11.9 Cell Therapies, Global Clinical Demand Analysis: Most Active Industry Players in Terms of Number of Trials Conducted
Figure 11.10 Cell Therapies, Global Clinical Demand Analysis: Most Active Non-Industry Players in Terms of Number of Trials Conducted
Figure 11.11 Cell Therapies, Global Clinical Demand Analysis: Distribution of Enrolled Patient Population by Type of Cell Therapy
Figure 11.12 Cell Therapies, Global Clinical Demand Analysis: Geographical Distribution of Enrolled Patient Population (Country-Wise)
Figure 11.13 Cell Therapies, Global Clinical Demand Analysis: Geographical Distribution of Enrolled Patient Population by Type of Cell Therapy and Trial Phase
Figure 11.14 Cell Therapies, Global Commercial Demand Analysis: Estimated Demand by Number of Product Approvals (2018, 2025 and 2030)
Figure 11.15 Cell Therapies, Global Commercial Demand Analysis: Estimated Demand by Target Patient Population (2018, 2025 and 2030)
Figure 12.1 Vaccines, Global Clinical Demand Analysis: Cumulative Distribution of Trials by Registration Year and Holding Temperature Range
Figure 12.2 Vaccines, Global Clinical Demand Analysis: Distribution of Trials by Holding Temperature Range
Figure 12.3 Vaccines, Global Clinical Demand Analysis: Distribution of Trials by Phase
Figure 12.4 Vaccines, Global Clinical Demand Analysis: Distribution of Trials by Status
Figure 12.5 Vaccines, Global Clinical Demand Analysis: Geographical Distribution of Trials (Country-Wise)
Figure 12.6 Vaccines, Global Clinical Demand Analysis: Geographical Distribution of Trials by Status and Phase
Figure 12.7 Vaccines, Global Clinical Demand Analysis: Distribution of Trials by Type of Sponsors / Collaborators
Figure 12.8 Vaccines, Global Clinical Demand Analysis: Most Active Industry Players in Terms of Number of Trials Conducted
Figure 12.9 Vaccines, Global Clinical Demand Analysis: Most Active Non-Industry Players in Terms of Number of Trials Conducted
Figure 12.10 Vaccines, Global Clinical Demand Analysis: Geographical Distribution of Enrolled Patient Population (Country-Wise)
Figure 12.11 Vaccines, Global Clinical Demand Analysis: Geographical Distribution of Enrolled Patient Population by Holding Temperature and Trial Phase
Figure 12.12 Vaccines, Global Commercial Demand Analysis: Distribution by Type of Vaccine
Figure 12.13 Mandatory Vaccines, Global Commercial Demand Analysis: Distribution by Geography (2018, 2025 and 2030)
Figure 12.14 Mandatory Vaccines, Commercial Demand Analysis: Distribution by Geography (Country-Wise, 2018 Scenario)
Figure 12.15 Mandatory Vaccines, Commercial Demand Analysis : Distribution by Geography (Country-Wise, 2025 Scenario)
Figure 12.16 Mandatory Vaccines, Commercial Demand Analysis : Distribution by Geography (Country-Wise, 2030 Scenario)
Figure 12.17 Optional Vaccines, Global Commercial Demand Analysis: Distribution by Geography (2018, 2025 and 2030)
Figure 12.18 Optional Vaccines, Commercial Demand Analysis : Distribution by Geography (Country-Wise, 2018 Scenario)
Figure 12.19 Optional Vaccines, Commercial Demand Analysis : Distribution by Geography (Country-Wise, 2025 Scenario)
Figure 12.20 Optional Vaccines, Commercial Demand Analysis : Distribution by Geography (Country-Wise, 2030 Scenario)
Figure 12.21 Vaccines, Global Commercial Demand Analysis: Estimated Demand by Patient Population (2018, 2025 and 2030)
Figure 12.22 Vaccines Global Commercial Demand Analysis: Estimated Demand by Number of Doses (2018, 2025 and 2030)
Figure 13.1 Human Organs, Global Demand Analysis: Distribution by Geography (2018, 2025 and 2030)
Figure 13.2 Human Organs, Global Demand Analysis: Distribution by Geography (Country-Wise, 2018 Scenario)
Figure 13.3 Human Organs, Global Demand Analysis: Distribution by Geography (Country-Wise, 2025 Scenario)
Figure 13.4 Human Organs, Global Demand Analysis: Distribution by Geography (Country-Wise, 2030 Scenario)
Figure 13.5 Human Organs, Global Demand: Distribution by Type of Organ (2018, 2025 and 2030)
Figure 13.6 Global Demand for Kidney: 2018, 2025 and 2030
Figure 13.7 Global Demand for Liver: 2018, 2025 and 2030
Figure 13.8 Global Demand for Heart: 2018, 2025 and 2030
Figure 13.9 Global Demand for Lung: 2018, 2025 and 2030
Figure 13.10 Global Demand for Intestine and Pancreas: 2018, 2025 and 2030
Figure 13.11 Human Organs, Overall Global Demand: 2018-2030
Figure 14.1 Global Cold Chain Logistics Market, 2018-2030: Base Scenario (USD Million)
Figure 14.2 Global Cold Chain Logistics Market: Share by Type of Product, 2018 and 2030 (USD Million, %)
Figure 14.3 Cold Chain Logistics Market for Cell Therapies, 2018-2030: Base Scenario (USD Million)
Figure 14.4 Cold Chain Logistics Market for Vaccines, 2018-2030: Base Scenario (USD Million)
Figure 14.5 Cold Chain Logistics Market for Human Organs, 2018-2030: Base Scenario (USD Million)
Figure 14.6 Global Cold Chain Logistics Market: Share by Holding Temperature Range, 2018 and 2030 (USD Million, %)
Figure 14.7 Cold Chain Logistics Market for Products Requiring Refrigerated Temperature, 2018-2030: Base Scenario (USD Million)
Figure 14.8 Cold Chain Logistics Market for Products Requiring Frozen Temperature, 2018-2030: Base Scenario (USD Million)
Figure 14.9 Cold Chain Logistics Market for Products Requiring Cryogenic Temperature, 2018-2030: Base Scenario (USD Million)
Figure 14.10 Global Cold Chain Logistics Market: Share by Type of Container, 2018 and 2030 (USD Million, %)
Figure 14.11 Cold Chain Logistics Market for Active Containers, 2018-2030: Base Scenario (USD Million)
Figure 14.12 Cold Chain Logistics Market for Passive Containers, 2018-2030: Base Scenario (USD Million)
Figure 14.13 Global Cold Chain Logistics Market: Share by Type of End-User, 2018 and 2030 (USD Million, %)
Figure 14.14 Cold Chain Logistics Market for Industry Players, 2018-2030: Base Scenario (USD Million)
Figure 14.15 Cold Chain Logistics Market for Non-Industry Players, 2018-2030: Base Scenario (USD Million)
Figure 14.16 Global Cold Chain Logistics Market: Share by Geography, 2018 and 2030 (USD Million, %)
Figure 14.17 Cold Chain Logistics Market in North America, 2018-2030: Base Scenario (USD Million)
Figure 14.18 Cold Chain Logistics Market in the US, 2018-2030: Base Scenario (USD Million)
Figure 14.19 Cold Chain Logistics Market in Canada, 2018-2030: Base Scenario (USD Million)
Figure 14.20 Cold Chain Logistics Market in Mexico, 2018-2030: Base Scenario (USD Million)
Figure 14.21 Cold Chain Logistics Market in Europe, 2018-2030: Base Scenario (USD Million)
Figure 14.22 Cold Chain Logistics Market in the UK, 2018-2030: Base Scenario (USD Million)
Figure 14.23 Cold Chain Logistics Market in Germany, 2018-2030: Base Scenario (USD Million)
Figure 14.24 Cold Chain Logistics Market in France, 2018-2030: Base Scenario (USD Million)
Figure 14.25 Cold Chain Logistics Market in Spain, 2018-2030: Base Scenario (USD Million)
Figure 14.26 Cold Chain Logistics Market in Italy, 2018-2030: Base Scenario (USD Million)
Figure 14.27 Cold Chain Logistics Market in Rest of Europe, 2018-2030: Base Scenario (USD Million)
Figure 14.28 Cold Chain Logistics Market in Asia-Pacific and Rest of the World, 2018-2030: Base Scenario (USD Million)
Figure 14.29 Cold Chain Logistics Market in Australia, 2018-2030: Base Scenario (USD Million)
Figure 14.30 Cold Chain Logistics Market in China, 2018-2030: Base Scenario (USD Million)
Figure 14.31 Cold Chain Logistics Market in Japan, 2018-2030: Base Scenario (USD Million)
Figure 14.32 Cold Chain Logistics Market in India, 2018-2030: Base Scenario (USD Million)
Figure 14.33 Cold Chain Logistics Market in Rest of the World, 2018-2030: Base Scenario (USD Million)
Figure 14.34 Cold Chain Logistics Market for Cell Therapies in North America, 2018-2030: Base Scenario (USD Million)
Figure 14.35 Cold Chain Logistics Market for Cell Therapies in the US, 2018-2030: Base Scenario (USD Million)
Figure 14.36 Cold Chain Logistics Market for Cell Therapies in Canada, 2018-2030: Base Scenario (USD Million)
Figure 14.37 Cold Chain Logistics Market for Cell Therapies in Mexico, 2018-2030: Base Scenario (USD Million)
Figure 14.38 Cold Chain Logistics Market for Cell Therapies in Europe, 2018-2030: Base Scenario (USD Million)
Figure 14.39 Cold Chain Logistics Market for Cell Therapies in the UK, 2018-2030: Base Scenario (USD Million)
Figure 14.40 Cold Chain Logistics Market for Cell Therapies in Germany, 2018-2030: Base Scenario (USD Million)
Figure 14.41 Cold Chain Logistics Market for Cell Therapies in France, 2018-2030: Base Scenario (USD Million)
Figure 14.42 Cold Chain Logistics Market for Cell Therapies in Spain, 2018-2030: Base Scenario (USD Million)
Figure 14.43 Cold Chain Logistics Market for Cell Therapies in Italy, 2018-2030: Base Scenario (USD Million)
Figure 14.44 Cold Chain Logistics Market for Cell Therapies in Rest of Europe, 2018-2030: Base Scenario (USD Million)
Figure 14.45 Cold Chain Logistics Market for Cell Therapies in Asia-Pacific and Rest of the World, 2018-2030: Base Scenario (USD Million)
Figure 14.46 Cold Chain Logistics Market for Cell Therapies in Australia, 2018-2030: Base Scenario (USD Million)
Figure 14.47 Cold Chain Logistics Market for Cell Therapies in China, 2018-2030: Base Scenario (USD Million)
Figure 14.48 Cold Chain Logistics Market for Cell Therapies in Japan, 2018-2030: Base Scenario (USD Million)
Figure 14.49 Cold Chain Logistics Market for Cell Therapies in India, 2018-2030: Base Scenario (USD Million)
Figure 14.50 Cold Chain Logistics Market for Cell Therapies in Rest of the World, 2018-2030: Base Scenario (USD Million)
Figure 14.51 Cold Chain Logistics Market for Vaccines in North America, 2018-2030: Base Scenario (USD Million)
Figure 14.52 Cold Chain Logistics Market for Vaccines in the US, 2018-2030: Base Scenario (USD Million)
Figure 14.53 Cold Chain Logistics Market for Vaccines in Canada, 2018-2030: Base Scenario (USD Million)
Figure 14.54 Cold Chain Logistics Market for Vaccines in Mexico, 2018-2030: Base Scenario (USD Million)
Figure 14.55 Cold Chain Logistics Market for Vaccines in Europe, 2018-2030: Base Scenario (USD Million)
Figure 14.56 Cold Chain Logistics Market for Vaccines in the UK, 2018-2030: Base Scenario (USD Million)
Figure 14.57 Cold Chain Logistics Market for Vaccines in Germany, 2018-2030: Base Scenario (USD Million)
Figure 14.58 Cold Chain Logistics Market for Vaccines in France, 2018-2030: Base Scenario (USD Million)
Figure 14.59 Cold Chain Logistics Market for Vaccines in Spain, 2018-2030: Base Scenario (USD Million)
Figure 14.60 Cold Chain Logistics Market for Vaccines in Italy, 2018-2030: Base Scenario (USD Million)
Figure 14.61 Cold Chain Logistics Market for Vaccines in Rest of Europe, 2018-2030: Base Scenario (USD Million)
Figure 14.62 Cold Chain Logistics Market for Vaccines in Asia-Pacific and Rest of the World, 2018-2030: Base Scenario (USD Million)
Figure 14.63 Cold Chain Logistics Market for Vaccines in Australia, 2018-2030: Base Scenario (USD Million)
Figure 14.64 Cold Chain Logistics Market for Vaccines in China, 2018-2030: Base Scenario (USD Million)
Figure 14.65 Cold Chain Logistics Market for Vaccines in Japan, 2018-2030: Base Scenario (USD Million)
Figure 14.66 Cold Chain Logistics Market for Vaccines in India, 2018-2030: Base Scenario (USD Million)
Figure 14.67 Cold Chain Logistics Market for Vaccines in Rest of the World, 2018-2030: Base Scenario (USD Million)
Figure 14.68 Cold Chain Logistics Market for Human Organs in North America, 2018-2030: Base Scenario (USD Million)
Figure 14.69 Cold Chain Logistics Market for Human Organs in the US, 2018-2030: Base Scenario (USD Million)
Figure 14.70 Cold Chain Logistics Market for Human Organs in Canada, 2018-2030: Base Scenario (USD Million)
Figure 14.71 Cold Chain Logistics Market for Human Organs in Mexico, 2018-2030: Base Scenario (USD Million)
Figure 14.72 Cold Chain Logistics Market for Human Organs in Europe, 2018-2030: Base Scenario (USD Million)
Figure 14.73 Cold Chain Logistics Market for Human Organs in the UK, 2018-2030: Base Scenario (USD Million)
Figure 14.74 Cold Chain Logistics Market for Human Organs in Germany, 2018-2030: Base Scenario (USD Million)
Figure 14.75 Cold Chain Logistics Market for Human Organs in France, 2018-2030: Base Scenario (USD Million)
Figure 14.76 Cold Chain Logistics Market for Human Organs in Spain, 2018-2030: Base Scenario (USD Million)
Figure 14.77 Cold Chain Logistics Market for Human Organs in Italy, 2018-2030: Base Scenario (USD Million)
Figure 14.78 Cold Chain Logistics Market for Human Organs in Rest of Europe, 2018-2030: Base Scenario (USD Million)
Figure 14.79 Cold Chain Logistics Market for Human Organs in Asia-Pacific and Rest of the World, 2018-2030: Base Scenario (USD Million)
Figure 14.80 Cold Chain Logistics Market for Human Organs in Australia, 2018-2030: Base Scenario (USD Million)
Figure 14.81 Cold Chain Logistics Market for Human Organs in China, 2018-2030: Base Scenario (USD Million)
Figure 14.82 Cold Chain Logistics Market for Human Organs in Japan, 2018-2030: Base Scenario (USD Million)
Figure 14.83 Cold Chain Logistics Market for Human Organs in India, 2018-2030: Base Scenario (USD Million)
Figure 14.84 Cold Chain Logistics Market for Human Organs in Rest of the World, 2018-2030: Base Scenario (USD Million)
Figure 14.85 Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in North America, 2018-2030: Base Scenario (USD Million)
Figure 14.86 Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in the US, 2018-2030: Base Scenario (USD Million)
Figure 14.87 Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Canada, 2018-2030: Base Scenario (USD Million)
Figure 14.88 Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Mexico, 2018-2030: Base Scenario (USD Million)
Figure 14.89 Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Europe, 2018-2030: Base Scenario (USD Million)
Figure 14.90 Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in the UK, 2018-2030: Base Scenario (USD Million)
Figure 14.91 Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Germany, 2018-2030: Base Scenario (USD Million)
Figure 14.92 Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in France, 2018-2030: Base Scenario (USD Million)
Figure 14.93 Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Spain, 2018-2030: Base Scenario (USD Million)
Figure 14.94 Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Italy, 2018-2030: Base Scenario (USD Million)
Figure 14.95 Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Rest of Europe, 2018-2030: Base Scenario (USD Million)
Figure 14.96 Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Asia-Pacific and Rest of the World, 2018-2030: Base Scenario (USD Million)
Figure 14.97 Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Australia, 2018-2030: Base Scenario (USD Million)
Figure 14.98 Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in China, 2018-2030: Base Scenario (USD Million)
Figure 14.99 Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Japan, 2018-2030: Base Scenario (USD Million)
Figure 14.100 Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in India, 2018-2030: Base Scenario (USD Million)
Figure 14.101 Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Rest of the World, 2018-2030: Base Scenario (USD Million)
Figure 14.102 Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in North America, 2018-2030: Base Scenario (USD Million)
Figure 14.103 Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in the US, 2018-2030: Base Scenario (USD Million)
Figure 14.104 Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Canada, 2018-2030: Base Scenario (USD Million)
Figure 14.105 Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Mexico, 2018-2030: Base Scenario (USD Million)
Figure 14.106 Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Europe, 2018-2030: Base Scenario (USD Million)
Figure 14.107 Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in the UK, 2018-2030: Base Scenario (USD Million)
Figure 14.108 Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Germany, 2018-2030: Base Scenario (USD Million)
Figure 14.109 Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in France, 2018-2030: Base Scenario (USD Million)
Figure 14.110 Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Spain, 2018-2030: Base Scenario (USD Million)
Figure 14.111 Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Italy, 2018-2030: Base Scenario (USD Million)
Figure 14.112 Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Rest of Europe, 2018-2030: Base Scenario (USD Million)
Figure 14.113 Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Asia-Pacific and Rest of the World, 2018-2030: Base Scenario (USD Million)
Figure 14.114 Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Australia, 2018-2030: Base Scenario (USD Million)
Figure 14.115 Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in China, 2018-2030: Base Scenario (USD Million)
Figure 14.116 Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Japan, 2018-2030: Base Scenario (USD Million)
Figure 14.117 Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in India, 2018-2030: Base Scenario (USD Million)
Figure 14.118 Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Rest of the World, 2018-2030: Base Scenario (USD Million)
Figure 14.119 Cold Chain Logistics Market for Active Containers in North America, 2018-2030: Base Scenario (USD Million)
Figure 14.120 Cold Chain Logistics Market for Active Containers in the US, 2018-2030: Base Scenario (USD Million)
Figure 14.121 Cold Chain Logistics Market for Active Containers in Canada, 2018-2030: Base Scenario (USD Million)
Figure 14.122 Cold Chain Logistics Market for Active Containers in Mexico, 2018-2030: Base Scenario (USD Million)
Figure 14.123 Cold Chain Logistics Market for Active Containers in Europe, 2018-2030: Base Scenario (USD Million)
Figure 14.124 Cold Chain Logistics Market for Active Containers in the UK, 2018-2030: Base Scenario (USD Million)
Figure 14.125 Cold Chain Logistics Market for Active Containers in Germany, 2018-2030: Base Scenario (USD Million)
Figure 14.126 Cold Chain Logistics Market for Active Containers in France, 2018-2030: Base Scenario (USD Million)
Figure 14.127 Cold Chain Logistics Market for Active Containers in Spain, 2018-2030: Base Scenario (USD Million)
Figure 14.128 Cold Chain Logistics Market for Active Containers in Italy, 2018-2030: Base Scenario (USD Million)
Figure 14.129 Cold Chain Logistics Market for Active Containers in Rest of Europe, 2018-2030: Base Scenario (USD Million)
Figure 14.130 Cold Chain Logistics Market for Active Containers in Asia-Pacific and Rest of the World, 2018-2030: Base Scenario (USD Million)
Figure 14.131 Cold Chain Logistics Market for Active Containers in Australia, 2018-2030: Base Scenario (USD Million)
Figure 14.132 Cold Chain Logistics Market for Active Containers in China, 2018-2030: Base Scenario (USD Million)
Figure 14.133 Cold Chain Logistics Market for Active Containers in Japan, 2018-2030: Base Scenario (USD Million)
Figure 14.134 Cold Chain Logistics Market for Active Containers in India, 2018-2030: Base Scenario (USD Million)
Figure 14.135 Cold Chain Logistics Market for Active Containers in Rest of the World, 2018-2030: Base Scenario (USD Million)
Figure 14.136 Cold Chain Logistics Market for Passive Containers in North America, 2018-2030: Base Scenario (USD Million)
Figure 14.137 Cold Chain Logistics Market for Passive Containers in the US, 2018-2030: Base Scenario (USD Million)
Figure 14.138 Cold Chain Logistics Market for Passive Containers in Canada, 2018-2030: Base Scenario (USD Million)
Figure 14.139 Cold Chain Logistics Market for Passive Containers in Mexico, 2018-2030: Base Scenario (USD Million)
Figure 14.140 Cold Chain Logistics Market for Passive Containers in Europe, 2018-2030: Base Scenario (USD Million)
Figure 14.141 Cold Chain Logistics Market for Passive Containers in the UK, 2018-2030: Base Scenario (USD Million)
Figure 14.142 Cold Chain Logistics Market for Passive Containers in Germany, 2018-2030: Base Scenario (USD Million)
Figure 14.143 Cold Chain Logistics Market for Passive Containers in France, 2018-2030: Base Scenario (USD Million)
Figure 14.144 Cold Chain Logistics Market for Passive Containers in Spain, 2018-2030: Base Scenario (USD Million)
Figure 14.145 Cold Chain Logistics Market for Passive Containers in Italy, 2018-2030: Base Scenario (USD Million)
Figure 14.146 Cold Chain Logistics Market for Passive Containers in Rest of Europe, 2018-2030: Base Scenario (USD Million) 
Figure 14.147 Cold Chain Logistics Market for Passive Containers in Asia-Pacific and Rest of the World, 2018-2030: Base Scenario (USD Million)
Figure 14.148 Cold Chain Logistics Market for Passive Containers in Australia, 2018-2030: Base Scenario (USD Million)
Figure 14.149 Cold Chain Logistics Market for Passive Containers in China, 2018-2030: Base Scenario (USD Million)
Figure 14.150 Cold Chain Logistics Market for Passive Containers in Japan, 2018-2030: Base Scenario (USD Million)
Figure 14.151 Cold Chain Logistics Market for Passive Containers in India, 2018-2030: Base Scenario (USD Million)
Figure 14.152 Cold Chain Logistics Market for Passive Containers in Rest of the World, 2018-2030: Base Scenario (USD Million)
Figure 14.153 Cold Chain Logistics Market for Industry Players in North America, 2018-2030: Base Scenario (USD Million)
Figure 14.154 Cold Chain Logistics Market for Industry Players in the US, 2018-2030: Base Scenario (USD Million)
Figure 14.155 Cold Chain Logistics Market for Industry Players in Canada, 2018-2030: Base Scenario (USD Million)
Figure 14.156 Cold Chain Logistics Market for Industry Players in Mexico, 2018-2030: Base Scenario (USD Million)
Figure 14.157 Cold Chain Logistics Market for Industry Players in Europe, 2018-2030: Base Scenario (USD Million)
Figure 14.158 Cold Chain Logistics Market for Industry Players in the UK, 2018-2030: Base Scenario (USD Million)
Figure 14.159 Cold Chain Logistics Market for Industry Players in Germany, 2018-2030: Base Scenario (USD Million)
Figure 14.160 Cold Chain Logistics Market for Industry Players in France, 2018-2030: Base Scenario (USD Million)
Figure 14.161 Cold Chain Logistics Market for Industry Players in Spain, 2018-2030: Base Scenario (USD Million)
Figure 14.162 Cold Chain Logistics Market for Industry Players in Italy, 2018-2030: Base Scenario (USD Million)
Figure 14.163 Cold Chain Logistics Market for Industry Players in Rest of Europe, 2018-2030: Base Scenario (USD Million)
Figure 14.164 Cold Chain Logistics Market for Industry Players in Asia-Pacific and Rest of the World, 2018-2030: Base Scenario (USD Million)
Figure 14.165 Cold Chain Logistics Market for Industry Players in Australia, 2018-2030: Base Scenario (USD Million)
Figure 14.166 Cold Chain Logistics Market for Industry Players in China, 2018-2030: Base Scenario (USD Million)
Figure 14.167 Cold Chain Logistics Market for Industry Players in Japan, 2018-2030: Base Scenario (USD Million)
Figure 14.168 Cold Chain Logistics Market for Industry Players in India, 2018-2030: Base Scenario (USD Million)
Figure 14.169 Cold Chain Logistics Market for Industry Players in Rest of the World, 2018-2030: Base Scenario (USD Million)
Figure 14.170 Cold Chain Logistics Market for Non-Industry Players in North America, 2018-2030: Base Scenario (USD Million)
Figure 14.171 Cold Chain Logistics Market for Non-Industry Players in the US, 2018-2030: Base Scenario (USD Million)
Figure 14.172 Cold Chain Logistics Market for Non-Industry Players in Canada, 2018-2030: Base Scenario (USD Million)
Figure 14.173 Cold Chain Logistics Market for Non-Industry Players in Mexico, 2018-2030: Base Scenario (USD Million)
Figure 14.174 Cold Chain Logistics Market for Non-Industry Players in Europe, 2018-2030: Base Scenario (USD Million)
Figure 14.175 Cold Chain Logistics Market for Non-Industry Players in the UK, 2018-2030: Base Scenario (USD Million)
Figure 14.176 Cold Chain Logistics Market for Non-Industry Players in Germany, 2018-2030: Base Scenario (USD Million)
Figure 14.177 Cold Chain Logistics Market for Non-Industry Players in France, 2018-2030: Base Scenario (USD Million)
Figure 14.178 Cold Chain Logistics Market for Non-Industry Players in Spain, 2018-2030: Base Scenario (USD Million)
Figure 14.179 Cold Chain Logistics Market for Non-Industry Players in Italy, 2018-2030: Base Scenario (USD Million)
Figure 14.180 Cold Chain Logistics Market for Non-Industry Players in Rest of Europe, 2018-2030: Base Scenario (USD Million)
Figure 14.181 Cold Chain Logistics Market for Non-Industry Players in Asia-Pacific and Rest of the World, 2018-2030: Base Scenario (USD Million)
Figure 14.182 Cold Chain Logistics Market for Non-Industry Players in Australia, 2018-2030: Base Scenario (USD Million)
Figure 14.183 Cold Chain Logistics Market for Non-Industry Players in China, 2018-2030: Base Scenario (USD Million)
Figure 14.184 Cold Chain Logistics Market for Non-Industry Players in Japan, 2018-2030: Base Scenario (USD Million)
Figure 14.185 Cold Chain Logistics Market for Non-Industry Players in India, 2018-2030: Base Scenario (USD Million)
Figure 14.186 Cold Chain Logistics Market for Non-Industry Players in Rest of the World, 2018-2030: Base Scenario (USD Million)
Figure 14.187 Global Cold Chain Logistics Market for Cell Therapies for Industry Players, 2018-2030: Base Scenario (USD Million)
Figure 14.188 Global Cold Chain Logistics Market for Cell Therapies for Non-Industry Players, 2018-2030: Base Scenario (USD Million)
Figure 14.189 Global Cold Chain Logistics Market for Vaccines for Industry Players, 2018-2030: Base Scenario (USD Million)
Figure 14.190 Global Cold Chain Logistics Market for Vaccines for Non-Industry Players, 2018-2030: Base Scenario (USD Million)
Figure 14.191 Global Cold Chain Logistics Market for Human Organs for Non-Industry Players, 2018-2030: Base Scenario (USD Million)
Figure 14.192 Global Cold Chain Logistics Market, 2018 and 2030: Conservative, Base and Optimistic Scenarios (USD Million)
Figure 15.1 Cold Chain Management in Healthcare: SWOT Analysis
Figure 15.2 Comparison of SWOT Factors: Harvey Ball Analysis
Figure 16.1 Connected Cold Chain Solutions: Process Flow Diagram
Figure 16.2 Artificial Intelligence in Cold Chain Logistics: Key Benefits and Challenges
Figure 16.3 Augmented Reality in Cold Chain Logistics: Key Benefits and Challenges
Figure 16.4 Automation and Robotics in Cold Chain Logistics: Key Benefits and Challenges
Figure 16.5 Big Data Analytics in Cold Chain Logistics: Key Benefits and Challenges
Figure 16.6 Blockchain Technology in Cold Chain Logistics: Key Benefits and Challenges
Figure 16.7 Cloud Computing in Cold Chain Logistics: Key Benefits and Challenges
Figure 16.8 Internet of Things in Cold Chain Logistics: Schematic Representation
Figure 16.9 Internet of Things in Cold Chain Logistics: Key Benefits and Challenges
Figure 16.10 RFID in Cold Chain Logistics: Key Benefits and Challenges
Figure 16.11 Connected Cold Chain: Future Growth Opportunities (Harvey Ball Analysis)
Figure 16.12 Real-Time Monitoring: Conventional Devices
Figure 16.13 RFID Based Real-Time Monitoring in Cold Chain Logistics
Figure 16.14 Key Contributions of Blockchain Technology and IoT in Real-Time Monitoring
Figure 16.15 Blockchain Technology and IoT Based Real-Time Monitoring: Flow Diagram
Figure 16.16 Real-Time Monitoring in Cold Chain Management: Growth Opportunities
Figure 16.17 Real-Time Monitoring: Reduction in Cold Chain Logistics Cost
 
List of Tables
Table 3.1 Comparison of Different Modes of Transportation
Table 4.1 Assessment Strategies for Cell Therapies
Table 4.2 Potential Strategies to Overcome Existing Challenges in Cell Therapy Logistics
Table 4.3 Classification of Vaccines based on Method of Development
Table 4.4 Recommended Holding Temperature Ranges for Different Type of Vaccines
Table 4.5 Logistics Complexity Analysis
Table 5.1 Cold Chain Logistics Service Providers: List of Industry Players
Table 5.2 Cold Chain Logistics Service Providers: Details on Type of Products
Table 5.3 Cold Chain Logistics Service Providers: Details on Services Offered
Table 5.4 Cold Chain Logistics Service Providers: Details on Mode of Transportation
Table 5.5 Cold Chain Logistics Service Providers: Details on Holding Temperature Range
Table 5.6 Cold Chain Logistics Service Providers: Details on Type of Container
Table 5.7 Cold Chain Logistics Service Providers: Details on Type of End-User
Table 5.8 Cold Chain Logistics Service Providers: Details on Geographical Activity
Table 5.9 Cold Chain Logistics Service Providers: Details on Location of Cold Chain Facility
Table 5.10 List of Cold Chain Logistics Service Providers for Other Healthcare Products
Table 5.11 List of Equipment / Technologies for Cold Chain Logistics
Table 6.1 Company Competitive Analysis: Small-sized Players
Table 6.2 Company Competitive Analysis: Mid-sized Players
Table 6.3 Company Competitive Analysis: Large Players
Table 7.1 Cold Chain Logistics Service Providers: List of Companies Profiled
Table 7.2 Cryoport: Key Highlights
Table 7.3 Cryoport: Recent Partnerships
Table 7.4 Cryoport: Future Outlook
Table 7.5 Lynden International Logistics: Key Highlights
Table 7.6 Lynden International Logistics: Future Outlook
Table 7.7 PAREXEL: Key Highlights
Table 7.8 PAREXEL: Future Outlook
Table 7.9 DHL Express: Key Highlights
Table 7.10 DHL Express: Recent Partnerships
Table 7.11 DHL Express: Future Outlook
Table 7.12 United Parcel Service: Key Highlights
Table 7.13 United Parcel Service: Recent Partnerships
Table 7.14 United Parcel Service: Future Outlook
Table 7.15 GAC: Key Highlights
Table 7.16 GAC: Future Outlook
Table 7.17 Yusen Logistics: Key Highlights
Table 7.18 Yusen Logistics: Recent Partnerships
Table 7.19 Yusen Logistics: Future Outlook
Table 8.1 Cold Chain Logistics in Healthcare: Partnerships and Collaborations, 2014-2018
Table 8.2 Cold Chain Logistics in Healthcare: List of Recent Expansions (2016-2018)
Table 10.1 List of USFDA Approved Drugs: Cold Chain Requirements (2014-2018)
Table 16.1 Artificial Intelligence in Cold Chain Logistics: List of Companies
Table 16.2 Automation and Robotics in Cold Chain Logistics: List of Companies
Table 16.3 Big Data Analytics in Cold Chain Logistics: List of Companies
Table 16.4 Blockchain Technology in Cold Chain Logistics: List of Companies
Table 16.5 Cloud Computing in Cold Chain Logistics: List of Companies
Table 16.6 Internet of Things in Cold Chain Logistics: List of Companies
Table 16.7 RFID Tags in Cold Chain Logistics: List of Companies
Table 17.1 AirBridgeCargo Airlines: Key Highlights
Table 17.2 Cell and Gene Therapy Catapult: Key Highlights
Table 17.3 UNICEF: Key Highlights
Table 17.4 Tabuk Pharmaceuticals: Key Highlights
Table 18.1 Cold Chain Logistics Service Providers: Distribution by Year of Establishment
Table 18.2 Cold Chain Logistics Service Providers: Distribution by Location of Headquarters
Table 18.3 Cold Chain Logistics Service Providers: Distribution by Size of Company
Table 18.4 Cold Chain Logistics Service Providers: Distribution by Size of Company and Geographical Location
Table 18.5 Cold Chain Logistics Service Providers: Distribution by Type of Products
Table 18.6 Cold Chain Logistics Service Providers: Distribution by Type of Cold Chain Logistics Services
Table 18.7 Cold Chain Logistics Service Providers: Distribution by Mode of Transportation
Table 18.8 Cold Chain Logistics Service Providers: Distribution by Holding Temperature Range
Table 18.9 Cold Chain Logistics Service Providers: Distribution by Type of Container
Table 18.10 Cold Chain Logistics Service Providers: Distribution by Type of End-User
Table 18.11 Cold Chain Logistics Service Providers: Distribution by Geographical Activity
Table 18.12 Cold Chain Logistics Service Providers: Distribution by Location of Cold Chain Facility (North America)
Table 18.13 Cold Chain Logistics Service Providers: Distribution by Location of Cold Chain Facility (Europe)
Table 18.14 Cold Chain Logistics Service Providers: Distribution by Location of Cold Chain Facility (Asia-Pacific and Rest of the World)
Table 18.15 Cryoport: Annual Revenues, 2014-H1 2018 (USD Million)
Table 18.16 PAREXEL: Annual Revenues, 2014-2017 (USD Million)
Table 18.17 DHL Express: Annual Revenues, 2014-H1 2018 (EUR Million)
Table 18.18 United Parcel Service: Annual Revenues, 2014-H1 2018 (USD Million)
Table 18.19 Yusen Logistics: Annual Revenues, 2014-H1 2018 (JPY Million)
Table 18.20 Partnerships and Collaborations: Cumulative Trend by Year (2014-2018)
Table 18.21 Partnerships and Collaborations: Distribution by Type of Partnership
Table 18.22 Partnerships and Collaborations: Cumulative Trend by Type of Partnership and Year (2014-2018)
Table 18.23 Partnerships and Collaborations: Distribution by Type of Product
Table 18.24 Partnerships and Collaborations: Distribution by Type of Cold Chain Logistics Service
Table 18.25 Partnerships and Collaborations: Cumulative Trend by Type of Cold Chain Logistics Service
Table 18.26 Partnerships and Collaborations: Most Active Players
Table 18.27 Partnerships and Collaborations: Regional Distribution
Table 18.28 Partnerships and Collaborations: Intercontinental and Intracontinental Distribution
Table 18.29 Mergers and Acquisitions: Most Active Acquirers
Table 18.30 Cold Chain Requirements for Approved Drugs (2014-2018): Analysis by Year of Approval
Table 18.31 Cold Chain Requirements for Approved Drugs (2014-2018): Analysis by Type of Molecule and Holding Temperature
Table 18.32 Cold Chain Requirements for Approved Biologics (2014-2018): Analysis by Type of Biologic
Table 18.33 Cold Chain Requirements for Approved Drugs (2014-2018): Analysis by Dosage Form and Holding Temperature
Table 18.34 Cold Chain Requirements for Approved Drugs (2014-2018): Analysis by Route of Administration and Holding Temperature
Table 18.35 Cold Chain Requirements for Approved Drugs (2014-2018): Most Active Players
Table 18.36 Cell Therapies, Global Clinical Demand Analysis: Cumulative Distribution of Trials by Registration Year
Table 18.37 Cell Therapies, Global Clinical Demand Analysis: Distribution of Trials by Type of Cell Therapy
Table 18.38 Cell Therapies, Global Clinical Demand Analysis: Distribution of Trials by Trial Phase
Table 18.39 Cell Therapies, Global Clinical Demand Analysis: Distribution of Trials by Type of Cell Therapy and Trial Phase
Table 18.40 Cell Therapies, Global Clinical Demand Analysis: Distribution of Trials by Therapeutic Indications
Table 18.41 Cell Therapies, Global Clinical Demand Analysis: Geographical Distribution by Number of Trials (Country-Wise)
Table 18.42 Cell Therapies, Global Clinical Demand Analysis: Geographical Distribution by Type of Cell Therapy and Trial Phase
Table 18.43 Cell Therapies, Global Clinical Demand Analysis: Distribution of Trials by Type of Sponsors / Collaborators
Table 18.44 Cell Therapies, Global Clinical Demand Analysis: Most Active Industry Players in Terms of Number of Trials Conducted
Table 18.45 Cell Therapies, Global Clinical Demand Analysis: Most Active Non-Industry Players in Terms of Number of Trials Conducted
Table 18.46 Cell Therapies, Global Clinical Demand Analysis: Distribution of Enrolled Patient Population by Type of Cell Therapy
Table 18.47 Cell Therapies, Global Clinical Demand Analysis: Geographical Distribution by Enrolled Patient Population (Country-Wise)
Table 18.48 Cell Therapies, Global Clinical Demand Analysis: Geographical Distribution of Enrolled Patient Population by Type of Cell Therapy and Trial Phase
Table 18.49 Cell Therapies, Global Commercial Demand Analysis: Estimated Demand by Number of Product Approvals (2018, 2025 and 2030)
Table 18.50 Cell Therapies, Global Commercial Demand: Estimated Demand by Target Patient Population (2018, 2025 and 2030)
Table 18.51 Vaccines, Global Clinical Demand Analysis: Cumulative Distribution of Trials by Registration Year and Holding Temperature Range
Table 18.52 Vaccines, Global Clinical Demand Analysis: Distribution of Trials by Holding Temperature Range
Table 18.53 Vaccines, Global Clinical Demand Analysis: Distribution of Trials by Trial Phase
Table 18.54 Vaccines, Global Clinical Demand Analysis: Distribution of Trials by Trial Status
Table 18.55 Vaccines, Global Clinical Demand Analysis: Geographical Distribution by Number of Trials (Country-Wise)
Table 18.56 Vaccines, Global Clinical Demand Analysis: Geographical Distribution by Trial Status and Trial Phase
Table 18.57 Vaccines, Global Clinical Demand Analysis: Distribution of Trials by Type of Sponsors / Collaborators
Table 18.58 Vaccines, Global Clinical Demand Analysis: Most Active Industry Players in Terms of Number of Trials Conducted
Table 18.59 Vaccines, Global Clinical Demand Analysis: Most Active Non-Industry Players in Terms of Number of Trials Conducted
Table 18.60 Vaccines Global Clinical Demand Analysis: Geographical Distribution by Enrolled Patient Population (Country-Wise)
Table 18.61 Vaccines, Global Clinical Demand Analysis: Geographical Distribution of Enrolled Patient Population by Holding Temperature and Trial Phase
Table 18.62 Vaccines, Global Commercial Demand Analysis: Distribution by Type of Vaccine
Table 18.63 Mandatory Vaccines, Global Commercial Demand Analysis: Distribution by Geography (2018, 2025 and 2030)
Table 18.64 Mandatory Vaccines, Commercial Demand Analysis: Distribution by Geography (Country-Wise, 2018 Scenario)
Table 18.65 Mandatory Vaccines, Commercial Demand Analysis : Distribution by Geography (Country-Wise, 2025 Scenario)
Table 18.66 Mandatory Vaccines, Commercial Demand Analysis : Distribution by Geography (Country-Wise, 2030 Scenario)
Table 18.67 Optional Vaccines, Global Commercial Demand Analysis: Distribution by Geography (2018, 2025 and 2030)
Table 18.68 Optional Vaccines, Commercial Demand Analysis : Distribution by Geography (Country-Wise, 2018 Scenario)
Table 18.69 Optional Vaccines, Commercial Demand Analysis : Distribution by Geography (Country-Wise, 2025 Scenario)
Table 18.70 Optional Vaccines, Commercial Demand Analysis : Distribution by Geography (Country-Wise, 2030 Scenario)
Table 18.71 Vaccines, Global Commercial Demand Analysis: Estimated Demand by Patient Population (2018, 2025 and 2030)
Table 18.72 Vaccines Global Commercial Demand Analysis: Estimated Demand by Number of Doses (2018, 2025 and 2030)
Table 18.73 Human Organs, Global Demand Analysis: Distribution by Geography (2018, 2025 and 2030)
Table 18.74 Human Organs, Global Demand Analysis: Distribution by Geography (Country-Wise, 2018 Scenario)
Table 18.75 Human Organs, Global Demand Analysis: Distribution by Geography (Country-Wise, 2025 Scenario)
Table 18.76 Human Organs, Global Demand Analysis: Distribution by Geography (Country-Wise, 2030 Scenario)
Table 18.77 Human Organs, Global Demand: Distribution by Type of Organ (2018, 2025 and 2030)
Table 18.78 Global Demand for Kidney: 2018, 2025 and 2030
Table 18.79 Global Demand for Liver: 2018, 2025 and 2030
Table 18.80 Global Demand for Heart: 2018, 2025 and 2030
Table 18.81 Global Demand for Lung: 2018, 2025 and 2030
Table 18.82 Global Demand for Intestine and Pancreas: 2018, 2025 and 2030
Table 18.83 Human Organs, Overall Global Demand: 2018-2030
Table 18.84 Global Cold Chain Logistics Market, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million) 
Table 18.85 Global Cold Chain Logistics Market: Share by Type of Product, 2018 and 2030 (USD Million, %)
Table 18.86 Cold Chain Logistics Market for Cell Therapies, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.87 Cold Chain Logistics Market for Vaccines, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.88 Cold Chain Logistics Market for Human Organs, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.89 Global Cold Chain Logistics Market: Share by Holding Temperature Range, 2018 and 2030: Conservative, Base and Optimistic Scenarios (USD Million, %)
Table 18.90 Cold Chain Logistics Market for Products Requiring Refrigerated Temperature, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.91 Cold Chain Logistics Market for Products Requiring Frozen Temperature, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.92 Cold Chain Logistics Market for Products Requiring Cryogenic Temperature, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.93 Global Cold Chain Logistics Market: Share by Type of Container, 2018 and 2030: Conservative, Base and Optimistic Scenarios (USD Million, %)
Table 18.94 Cold Chain Logistics Market for Active Containers, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.95 Cold Chain Logistics Market for Passive Containers, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.96 Global Cold Chain Logistics Market: Share by Type of End-User, 2018 and 2030: Conservative, Base and Optimistic Scenarios (USD Million, %)
Table 18.97 Cold Chain Logistics Market for Industry Players, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.98 Cold Chain Logistics Market for Non-Industry Players, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.99 Global Cold Chain Logistics Market: Share by Geography, 2018 and 2030: Conservative, Base and Optimistic Scenarios (USD Million, %)
Table 18.100 Cold Chain Logistics Market in North America, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.101 Cold Chain Logistics Market in the US, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.102 Cold Chain Logistics Market in Canada, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.103 Cold Chain Logistics Market in Mexico, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.104 Cold Chain Logistics Market in Europe, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.105 Cold Chain Logistics Market in the UK, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.106 Cold Chain Logistics Market in Germany, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.107 Cold Chain Logistics Market in France, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.108 Cold Chain Logistics Market in Spain, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.109 Cold Chain Logistics Market in Italy, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.110 Cold Chain Logistics Market in Rest of Europe, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.111 Cold Chain Logistics Market in Asia-Pacific and Rest of the World, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.112 Cold Chain Logistics Market in Australia, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.113 Cold Chain Logistics Market in China, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.114 Cold Chain Logistics Market in Japan, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.115 Cold Chain Logistics Market in India, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.116 Cold Chain Logistics Market in Rest of the World, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.117 Cold Chain Logistics Market for Cell Therapies in North America, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.118 Cold Chain Logistics Market for Cell Therapies in the US, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.119 Cold Chain Logistics Market for Cell Therapies in Canada, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.120 Cold Chain Logistics Market for Cell Therapies in Mexico, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.121 Cold Chain Logistics Market for Cell Therapies in Europe, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.122 Cold Chain Logistics Market for Cell Therapies in the UK, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.123 Cold Chain Logistics Market for Cell Therapies in Germany, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.124 Cold Chain Logistics Market for Cell Therapies in France, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.125 Cold Chain Logistics Market for Cell Therapies in Spain, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.126 Cold Chain Logistics Market for Cell Therapies in Italy, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.127 Cold Chain Logistics Market for Cell Therapies in Rest of Europe, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.128 Cold Chain Logistics Market for Cell Therapies in Asia-Pacific and Rest of the World, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.129 Cold Chain Logistics Market for Cell Therapies in Australia, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.130 Cold Chain Logistics Market for Cell Therapies in China, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.131 Cold Chain Logistics Market for Cell Therapies in Japan, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.132 Cold Chain Logistics Market for Cell Therapies in India, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.133 Cold Chain Logistics Market for Cell Therapies in Rest of the World, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.134 Cold Chain Logistics Market for Vaccines in North America, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.135 Cold Chain Logistics Market for Vaccines in the US, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.136 Cold Chain Logistics Market for Vaccines in Canada, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.137 Cold Chain Logistics Market for Vaccines in Mexico, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.138 Cold Chain Logistics Market for Vaccines in Europe, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.139 Cold Chain Logistics Market for Vaccines in the UK, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.140 Cold Chain Logistics Market for Vaccines in Germany, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.141 Cold Chain Logistics Market for Vaccines in France, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.142 Cold Chain Logistics Market for Vaccines in Spain, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.143 Cold Chain Logistics Market for Vaccines in Italy, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.144 Cold Chain Logistics Market for Vaccines in Rest of Europe, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.145 Cold Chain Logistics Market for Vaccines in Asia-Pacific and Rest of the World, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.146 Cold Chain Logistics Market for Vaccines in Australia, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.147 Cold Chain Logistics Market for Vaccines in China, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.148 Cold Chain Logistics Market for Vaccines in Japan, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.149 Cold Chain Logistics Market for Vaccines in India, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.150 Cold Chain Logistics Market for Vaccines in Rest of the World, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.151 Cold Chain Logistics Market for Human Organs in North America, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.152 Cold Chain Logistics Market for Human Organs in the US, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.153 Cold Chain Logistics Market for Human Organs in Canada, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.154 Cold Chain Logistics Market for Human Organs in Mexico, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.155 Cold Chain Logistics Market for Human Organs in Europe, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.156 Cold Chain Logistics Market for Human Organs in the UK, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.157 Cold Chain Logistics Market for Human Organs in Germany, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.158 Cold Chain Logistics Market for Human Organs in France, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.159 Cold Chain Logistics Market for Human Organs in Spain, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.160 Cold Chain Logistics Market for Human Organs in Italy, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.161 Cold Chain Logistics Market for Human Organs in Rest of Europe, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.162 Cold Chain Logistics Market for Human Organs in Asia-Pacific and Rest of the World, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.163 Cold Chain Logistics Market for Human Organs in Australia, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.164 Cold Chain Logistics Market for Human Organs in China, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.165 Cold Chain Logistics Market for Human Organs in Japan, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.166 Cold Chain Logistics Market for Human Organs in India, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.167 Cold Chain Logistics Market for Human Organs in Rest of the World, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.168 Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in North America, 2018-2030: Conservative, Base and Optimistic Scenarios (USD 
Million)
Table 18.169 Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in the US, 2018-2030: Conservative, Base and Optimistic Scenarios (USD 
Million)
Table 18.170 Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Canada, 2018-2030: Conservative, Base and Optimistic Scenarios (USD 
Million)
Table 18.171 Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Mexico, 2018-2030: Conservative, Base and Optimistic Scenarios (USD 
Million)
Table 18.172 Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Europe, 2018-2030: Conservative, Base and Optimistic Scenarios (USD 
Million)
Table 18.173 Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in the UK, 2018-2030: Conservative, Base and Optimistic Scenarios (USD 
Million)
Table 18.174 Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Germany, 2018-2030: Conservative, Base and Optimistic Scenarios (USD 
Million)
Table 18.175 Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in France, 2018-2030: Conservative, Base and Optimistic Scenarios (USD 
Million)
Table 18.176 Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Spain, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.177 Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Italy, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.178 Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Rest of Europe, 2018-2030: Conservative, Base and Optimistic Scenarios (USD 
Million)
Table 18.179 Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Asia-Pacific and Rest of the World, 2018-2030: Conservative, Base and 
Optimistic Scenarios (USD Million)
Table 18.180 Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Australia, 2018-2030: Conservative, Base and Optimistic Scenarios (USD 
Million)
Table 18.181 Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in China, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.182 Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Japan, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.183 Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in India, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.184 Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Rest of the World, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.185 Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in North America, 2018-2030: Conservative, Base and Optimistic 
Scenarios (USD Million)
Table 18.186 Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in the US, 2018-2030: Conservative, Base and Optimistic Scenarios (USD 
Million)
Table 18.187 Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Canada, 2018-2030: Conservative, Base and Optimistic Scenarios (USD 
Million)
Table 18.188 Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Mexico, 2018-2030: Conservative, Base and Optimistic Scenarios (USD 
Million)
Table 18.189 Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Europe, 2018-2030: Conservative, Base and Optimistic Scenarios (USD 
Million)
Table 18.190 Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in the UK, 2018-2030: Conservative, Base and Optimistic Scenarios (USD 
Million)
Table 18.191 Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Germany, 2018-2030: Conservative, Base and Optimistic Scenarios 
(USD Million)
Table 18.192 Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in France, 2018-2030: Conservative, Base and Optimistic Scenarios (USD 
Million)
Table 18.193 Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Spain, 2018-2030: Conservative, Base and Optimistic Scenarios (USD 
Million)
Table 18.194 Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Italy, 2018-2030: Conservative, Base and Optimistic Scenarios (USD 
Million)
Table 18.195 Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Rest of Europe, 2018-2030: Conservative, Base and Optimistic 
Scenarios (USD Million)
Table 18.196 Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Asia-Pacific and Rest of the World, 2018-2030: Conservative, Base 
and Optimistic Scenarios (USD Million)
Table 18.197 Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Australia, 2018-2030: Conservative, Base and Optimistic Scenarios 
(USD Million)
Table 18.198 Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in China, 2018-2030: Conservative, Base and Optimistic Scenarios (USD 
Million)
Table 18.199 Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Japan, 2018-2030: Conservative, Base and Optimistic Scenarios (USD 
Million)
Table 18.200 Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in India, 2018-2030: Conservative, Base and Optimistic Scenarios (USD 
Million)
Table 18.201 Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Rest of the World, 2018-2030: Conservative, Base and Optimistic 
Scenarios (USD Million)
Table 18.202 Cold Chain Logistics Market for Active Containers in North America, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.203 Cold Chain Logistics Market for Active Containers in the US, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.204 Cold Chain Logistics Market for Active Containers in Canada, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.205 Cold Chain Logistics Market for Active Containers in Mexico, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.206 Cold Chain Logistics Market for Active Containers in Europe, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.207 Cold Chain Logistics Market for Active Containers in the UK, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.208 Cold Chain Logistics Market for Active Containers in Germany, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.209 Cold Chain Logistics Market for Active Containers in France, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.210 Cold Chain Logistics Market for Active Containers in Spain, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.211 Cold Chain Logistics Market for Active Containers in Italy, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.212 Cold Chain Logistics Market for Active Containers in Rest of Europe, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.213 Cold Chain Logistics Market for Active Containers in Asia-Pacific and Rest of the World, 2018-2030: Conservative, Base and Optimistic Scenarios (USD 
Million)
Table 18.214 Cold Chain Logistics Market for Active Containers in Australia, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.215 Cold Chain Logistics Market for Active Containers in China, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.216 Cold Chain Logistics Market for Active Containers in Japan, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.217 Cold Chain Logistics Market for Active Containers in India, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.218 Cold Chain Logistics Market for Active Containers in Rest of the World, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.219 Cold Chain Logistics Market for Passive Containers in North America, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.220 Cold Chain Logistics Market for Passive Containers in the US, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.221 Cold Chain Logistics Market for Passive Containers in Canada, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.222 Cold Chain Logistics Market for Passive Containers in Mexico, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.223 Cold Chain Logistics Market for Passive Containers in Europe, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.224 Cold Chain Logistics Market for Passive Containers in the UK, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.225 Cold Chain Logistics Market for Passive Containers in Germany, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.226 Cold Chain Logistics Market for Passive Containers in France, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.227 Cold Chain Logistics Market for Passive Containers in Spain, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.228 Cold Chain Logistics Market for Passive Containers in Italy, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.229 Cold Chain Logistics Market for Passive Containers in Rest of Europe, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.230 Cold Chain Logistics Market for Passive Containers in Asia-Pacific and Rest of the World, 2018-2030: Conservative, Base and Optimistic Scenarios (USD 
Million)
Table 18.231 Cold Chain Logistics Market for Passive Containers in Australia, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.232 Cold Chain Logistics Market for Passive Containers in China, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.233 Cold Chain Logistics Market for Passive Containers in Japan, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.234 Cold Chain Logistics Market for Passive Containers in India, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.235 Cold Chain Logistics Market for Passive Containers in Rest of the World, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.236 Cold Chain Logistics Market for Industry Players in North America, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.237 Cold Chain Logistics Market for Industry Players in the US, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.238 Cold Chain Logistics Market for Industry Players in Canada, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.239 Cold Chain Logistics Market for Industry Players in Mexico, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.240 Cold Chain Logistics Market for Industry Players in Europe, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.241 Cold Chain Logistics Market for Industry Players in the UK, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.242 Cold Chain Logistics Market for Industry Players in Germany, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.243 Cold Chain Logistics Market for Industry Players in France, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.244 Cold Chain Logistics Market for Industry Players in Spain, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.245 Cold Chain Logistics Market for Industry Players in Italy, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.246 Cold Chain Logistics Market for Industry Players in Rest of Europe, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.247 Cold Chain Logistics Market for Industry Players in Asia-Pacific and Rest of the World, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.248 Cold Chain Logistics Market for Industry Players in Australia, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.249 Cold Chain Logistics Market for Industry Players in China, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.250 Cold Chain Logistics Market for Industry Players in Japan, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.251 Cold Chain Logistics Market for Industry Players in India, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.252 Cold Chain Logistics Market for Industry Players in Rest of the World, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.253 Cold Chain Logistics Market for Non-Industry Players in North America, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.254 Cold Chain Logistics Market for Non-Industry Players in the US, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.255 Cold Chain Logistics Market for Non-Industry Players in Canada, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.256 Cold Chain Logistics Market for Non-Industry Players in Mexico, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.257 Cold Chain Logistics Market for Non-Industry Players in Europe, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.258 Cold Chain Logistics Market for Non-Industry Players in the UK, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.259 Cold Chain Logistics Market for Non-Industry Players in Germany, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.260 Cold Chain Logistics Market for Non-Industry Players in France, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.261 Cold Chain Logistics Market for Non-Industry Players in Spain, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.262 Cold Chain Logistics Market for Non-Industry Players in Italy, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.263 Cold Chain Logistics Market for Non-Industry Players in Rest of Europe, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.264 Cold Chain Logistics Market for Non-Industry Players in Asia-Pacific and Rest of the World, 2018-2030: Conservative, Base and Optimistic Scenarios (USD 
Million)
Table 18.265 Cold Chain Logistics Market for Non-Industry Players in Australia, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.266 Cold Chain Logistics Market for Non-Industry Players in China, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.267 Cold Chain Logistics Market for Non-Industry Players in Japan, 2018-2030 (USD Million) : Conservative, Base and Optimistic Scenarios
Table 18.268 Cold Chain Logistics Market for Non-Industry Players in India, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.269 Cold Chain Logistics Market for Non-Industry Players in Rest of the World, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.270 Global Cold Chain Logistics Market for Cell Therapies for Industry Players, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.271 Global Cold Chain Logistics Market for Cell Therapies for Non-Industry Players, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.272 Global Cold Chain Logistics Market for Vaccines for Industry Players, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.273 Global Cold Chain Logistics Market for Vaccines for Non-Industry Players, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.274 Global Cold Chain Logistics Market for Human Organs for Non-Industry Players, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 18.275 Global Cold Chain Logistics Market, 2018 and 2030: Conservative, Base and Optimistic Scenarios (USD Million) 
 
List of Companies
The following companies / institutes / government bodies and organizations have been mentioned in this report.
1. 1st Response Medical Services
2. 5NINES
3. AB Oxford Cold Storage
4. A+P Grupo
5. AbbVie
6. Abu Dhabi Medical Devices
7. ACADIA Pharmaceuticals
8. Accelogix
9. Accucold
10. Accuristix
11. Achaogen
12. Actelion Pharmaceuticals
13. Adaptimmune Therapeutics
14. Advanced Accelerator Applications
15. Advantage Parcel Express (Apex)
16. Aerie Pharmaceuticals
17. AeroCare Medical Transport System
18. AeroSafe Global
19. Agility Logistics
20. Agios Pharmaceuticals
21. AI Shifa Medical Syringes
22. Air Canada Cargo
23. Air France KLM Martinair Cargo
24. Air Liquide 
25. AirBridgeCargo Airlines
26. Airmax
27. Airmedic
28. AIT Worldwide Logistics
29. AkaRx
30. Alba Smart Automation
31. Alcon Laboratories
32. Alexion Pharmaceuticals
33. Alia MedFlight
34. Alibaba Group
35. Alkermes
36. Allergan
37. Almac Group
38. Alpine Air Ambulance
39. Ambetronics Engineers
40. American Airlines Cargo
41. American Society of Gene and Cell Therapy 
42. AmerisourceBergen
43. Amgen
44. Amson Vaccines & Pharma
45. Anacor Pharmaceuticals
46. Anhui Tiankang Medical Technology
47. AntTail
48. Anwood Logistics Systems
49. AOV International
50. Apex International
51. American President Lines
52. Aqua Logistics
53. Aramex
54. Arcticold Logistics
55. ARIAD Pharmaceuticals
56. Array BioPharma
57. Assa Abloy
58. AssetTrackr
59. Astellas Pharma
60. AstraZeneca
61. Atelerix
62. dnstruments
63. AUCMA
64. Aviators Air Rescue
65. B Medical Systems
66. Bachem
67. Badu (Xiamen) Technology
68. Balaji Distributors
69. Bausch & Lomb
70. Bayer 
71. Baylor College of Medicine
72. Be The Match BioTherapies
73. Becton Dickinson
74. Belglobe
75. Bennett International Group
76. Berlinger
77. Beyond Wireless Technology
78. Bio Pharma Logistics
79. Biocair
80. BioCision
81. BioCryst Pharmaceuticals
82. Biogen
83. BioLife Solutions
84. BioMarin Pharmaceutical
85. BioSpeciMan
86. Biostor Ireland
87. BioStorage Technologies
88. Biotec Services International
89. Biotech & Pharma Logistics
90. Blackcoffer
91. Bloodworks Northwest
92. Blowkings
93. Blue Earth
94. Bluechiip
95. BluLine Solutions
96. Boehringer Ingelheim
97. Bollore Logistics
98. Boston Biomedical 
99. Boxcold Logistics
100. Bracco Diagnostics
101. Brigham and Women's Hospital
102. Bristol-Myers Squibb
103. Broekman Logistics
104. Brooks Life Sciences
105. Burris Logistics
106. CA Transport
107. CAL Cargo Airlines
108. Camio Logisticss
109. Cardinal Health
110. CargoSense
111. Catalent 
112. Cell and Gene Therapy Catapult
113. Centers for Disease Control and Prevention
114. Cause Analytics
115. Cavalier Logistics
116. Celgene
117. Centrofarm
118. CEVA Logistics
119. Chain.io
120. Channel Freight Services 
121. Chart Industries
122. Chase Doors
123. Chelsea Therapeutics
124. Chemo Research
125. Chengdu Xinjin Shifeng Medical Apparatus & Instrument
126. Chiesi USA
127. Chilled Logistics
128. Chiltern Cold Storage Group
129. Chimera Biotec
130. CHS Air Logistics
131. City Xpress Delivery
132. Cleveland Cord Blood Center
133. ClinImmune Labs
134. Clovis Oncology
135. Coastal Pacific Xpress
136. Cold Box Express
137. Cold Chain IQ
138. Cold Chain Technologies
139. ColdEX Logistics
140. CombiMatrix
141. Comprehensive Care
142. Continental Cargo
143. Conveyor Uni Express
144. Cool Lab
145. CoolPac
146. Cooltrax
147. Corex 
148. Critical Path
149. Cryo Express
150. Cryo Store
151. Cryopak 
152. Cryoport
153. Crystal Logistic Cool Chain
154. CSafe Global
155. CSM
156. CTI Cold Chain
157. Cubist Pharmaceuticals
158. Carlson Wagonlit Travel
159. CyberFreight
160. Daiichi Sankyo
161. Dana-Farber Cancer Institute
162. DB Schenker
163. Deliver Plus
164. Delta Cargo
165. Delta UK Express
166. DeltaTrak
167. Dendreon
168. DHL Express
169. Diamond Couriers
170. Digital Supply Chain Institute 
171. DilinxRFID
172. DiscGenics
173. Dooile
174. DSV
175. Duke University School of Medicine
176. Dulas
177. DuPont
178. Durata Therapeutics
179. Dynamox
180. Eisai
181. Eli Lilly
182. Elitech
183. ELPRO-BUCHS
184. Elusys Therapeutics
185. EMD Serono
186. Emergent Cold
187. ENLAKE
188. Enterra Solutions
189. Envirotainer
190. EPx Logistics
191. Escort Cold Chain Solutions
192. Ethiopian Airlines
193. European Air Ambulance
194. Eurosoft Systems
195. EVARA
196. EXAM Transport
197. Exel
198. Expeditors
199. Exusia
200. FactR Pay
201. FarEye
202. FedEx
203. Ferrer
204. Fibrocell Technologies
205. Finnair Cargo
206. FinSigur
207. First Care Ambulance
208. Fisher BioServices
209. FluidX
210. Force Logistics
211. FOSTER Refrigerator
212. Franzosini
213. Freight Lines
214. FreightWaves
215. Fresenius Kabi
216. Freshliance Electronics
217. GAC
218. Gary Heer Transport
219. Gati
220. Gati Kausar
221. Gavi
222. GE Healthcare
223. GENCO Distribution System
224. Genentech
225. Genomic and Immunotherapy Medical Institute
226. Genzyme 
227. GEODIS
228. Georgia Institute of Technology 
229. Georgia Research Alliance 
230. Georgian Express Special
231. Gilead Sciences
232. Giostyle
233. GlaxoSmithKline
234. Global Cold Chain Alliance
235. Global Cold Chain Solutions
236. Godrej & Boyce
237. Gold Cold Transport
238. GP Logistics
239. Gradalis
240. Greenwich Biosciences
241. Grieshaber
242. Guangdong Haiou Medical Apparatus
243. H.Essers
244. H. Lee Moffitt Cancer Center & Research Institute
245. Haier Bio-Medical and Laboratory
246. HAVI
247. Heat Biologics
248. Heaven Sent Couriers
249. Helapet
250. Helix Research Center
251. Helm Medical
252. Helmer Scientific
253. Helsinn Healthcare
254. Hindustan Syringes & Medical Devices
255. Honeywell International
256. IBM
257. Institut Georges Lopez
258. Igloo Thermo-Logistics
259. iMedical Austria
260. IMP
261. Immunitor
262. INFINITECH INDIA
263. Infistics Solutions
264. INKBIRD
265. Inseltrade 
266. IntelliQuick Delivery
267. Intercept Pharmaceuticals
268. Interlink Courier Services
269. Intermountain Life Flight
270. International Company for Medical Necessities
271. Interstate Cold Storage
272. Iovance Biotherapeutics
273. Ironwood Pharmaceuticals
274. Janssen Biotech
275. Jazz Pharmaceuticals
276. Jiangxi Hongda Medical Equipment Group
277. Jiangxi Sanxin Medtec
278. Jigsaw Medical
279. JJX Logistics
280. JMI Syringes & Medical Devices 
281. Jones Packaging
282. Juno Therapeutics
283. KAI Pharmaceuticals
284. Kalibox
285. KCAS Bioanalytical Services and Biomarker Services
286. Kenco Group
287. Keppel Logistics
288. Kerry Logistics
289. Kaspect
290. Khaas Logistics
291. Kite Pharma
292. KN PharmaChain 
293. Kospa Logistic Services
294. Kuehne + Nagel International
295. KWE Global Logistics Partner
296. Kythera Biopharmaceuticals
297. L&M Transportation Services
298. La Jolla Pharmaceutical 
299. Lamprecht Transport
300. LARION
301. Lateral emSoft
302. Lattice Biologics
303. Lettuce Box
304. Lexicon Pharmaceuticals
305. LifeConEx
306. Lifeline Scientific
307. LifeScience Logistics
308. LifeSouth Community Blood Centers
309. Lincs Medical Services
310. Lisaline Lifescience Technologies
311. LogTag Recorders
312. Lufthansa Cargo
313. Lupin
314. LyddAir
315. Lynden International Logistics
316. Mandai Link Logistics
317. Marken
318. Masters Speciality Pharma
319. Massachusetts General Hospital
320. MaxiTrack Sensors
321. Mayo Clinic 
322. McArdle Skeath
323. McKesson
324. McLanachan Transport
325. MD Anderson Cancer Center 
326. MD Logistics
327. MD Stem Cells 
328. MDS Logistics
329. MedCision
330. MediBest Group
331. Medical-Moves
332. Medical Intertrade
333. Medicines Development for Global Health
334. Melinta Therapeutics
335. Merck
336. MeshWorks Wireless
337. MET Medical
338. MethodologyMatch
339. Micro Q Technologies
340. Mile High Ambulance
341. Millennium Pharmaceuticals
342. MILS Cold Chain Logistics
343. Mitra Rajawali Banjaran
344. Mitsubishi Tanabe Pharma
345. MNX Global Logistics
346. Morphotek
347. Mymetics
348. NantKwest
349. National Cancer Institute
350. National Cell Manufacturing Consortium 
351. National Centre for Control of Vaccines and Biologicals 
352. National Institute of Allergy and Infectious Diseases
353. National Institute of Hygiene and Epidemiology
354. National Heart, Lung, and Blood Institute 
355. National Institutes of Health
356. National Institute of Standards and Technology
357. Neomedic
358. Neurocrine Biosciences
359. New York Blood Center
360. NexG
361. Nexleaf Analytics
362. NextPakk
363. Nichirei Logistics Group
364. Nilkamal
365. Nohla Therapeutics
366. NORA
367. Nordic Cold Storage
368. Northern Alliance Advanced Therapies Treatment Centre
369. Novartis
370. Novo Nordisk
371. NPS Pharmaceuticals
372. One Network Enterprises
373. Oneject
374. OpenPort
375. Optimize Courier
376. Organ Recovery Systems
377. Organ Transport Systems
378. ORGANE LOGISTIQUE
379. Organogenesis
380. Organon International
381. Otsuka Pharmaceutical
382. Pacific Bio-Material Management
383. Pa-Hu 
384. Paladin Labs
385. Pan Asia Logistics
386. Panalpina
387. Paragonix Technologies
388. Parazelsus
389. Parekh Integrated Services 
390. PAREXEL
391. PATH 
392. PC Medical Support Services
393. PDP Couriers
394. PDQ Couriers
395. Pelican BioThermal
396. Pfenning Logistics
397. Pfizer
398. Pharma Premier Logistics
399. PharmaJet
400. PharmaServ Express
401. Pharmaserv Logistics
402. Phil Med Alliance
403. Piramal Imaging
404. Polar Thermal
405. POLYNOR
406. Porkka
407. Portola Pharmaceuticals
408. PostNL Belgium
409. Priority Solutions International
410. Prodlekpol
411. ProMab Biotechnologies
412. Protek Pharma Worldwide
413. PTC Therapeutics
414. Puma Biotechnology
415. Purolator
416. Qatari German Company for Medical Devices
417. QCMedchain
418. QPCON
419. Quick International Courier
420. QuickSTAT 
421. Raaziq International
422. Radius Health
423. Raes Pharmaceutical Logistics
424. Raghava Warehousing & Logistic Services
425. RALU Logistics
426. REFCOLD India
427. ReFlow
428. Regeneron Pharmaceuticals
429. Relypsa
430. Remonsys
431. Rempex Pharmaceuticals
432. Retractable Technologies
433. Retro Culture
434. Retrophin 
435. REVA
436. Revital Healthcare
437. Rhenus Logistics
438. Rigel Pharmaceuticals
439. Roambee
440. Roche
441. Rogue Transportation 
442. Royal Group
443. RURO
444. Safeguard Medical Services
445. SameDay Logistics
446. Sanaria
447. Sanofi
448. Sarepta Therapeutics
449. SAVSU Technologies
450. SCALE AI
451. Schechter Tech
452. SciSafe
453. SEKO Worldwide
454. Sensitech
455. Sentry Biopharma Services
456. Seo Chemical
457. Sequel Logistics
458. SF Express
459. Sharif Tarasheh
460. Shionogi
461. ShipChain
462. Shire
463. Sidney Kimmel Comprehensive Cancer Center
464. Sierra Molecular 
465. SIGA Technologies
466. Sinobioway Cell Therapy
467. Sinopharm Logistics
468. Sky Fresh
469. SkyCell
470. Smurfit Kappa Lagamill
471. Snowman Logistics
472. SNZOR
473. Sofrigam
474. Sol-Millennium Medical Group
475. South Medical Jets
476. Spark Therapeutics
477. Spectrum Pharmaceuticals
478. Sprout Pharmaceuticals
479. SS Supply Chain Solutions
480. SSG UK Specialist Ambulance Service
481. SSM Health Cardinal Glennon Children's Hospital
482. Star Service
483. Stellapps Technologies
484. Stellar Value Chain Solutions
485. Stemedica Cell Technologies
486. Strongbridge Biopharma
487. Sun Pharma Global
488. SunDanzer Refrigeration
489. Supply Today
490. SwanLeap
491. Sweetbridge
492. Swift Cold Chain Group
493. Swire Cold Chain Logistics
494. Swire Cold Storage
495. Swisslog Holding
496. Switrace
497. Synergy Pharmaceuticals
498. TAG Sensors
499. Taiho Oncology
500. TaiMed Biologics
501. Takeda Pharmaceutical
502. Taylor-Wharton
503. Transport Corporation of India
504. TCP Logistics
505. Tej Couriers
506. Temperature Sensitive Solutions
507. Temperature@lert
508. TempSen Electronics 
509. Temptime
510. TESARO
511. Teva Pharmaceutical 
512. Thaddeus Medical Systems
513. The Alliance
514. The Medicines Company
515. Therapak
516. Thermo Fisher Scientific 
517. TiGenix
518. Tiger Logistics
519. Time Definite Services
520. time:matters
521. Timestrip
522. TLX Cargo
523. TNT Express
524. Tonnindo Eramulya
525. Touchdown International
526. TOWER Cold Chain Solutions
527. TrakCel
528. TransMedics
529. Transplanning
530. Trinity Air Ambulance International
531. Trinity Air Medical
532. Tripharma Logistics
533. TVS Asianics 
534. Ultragenyx Pharmaceutical
535. Union Chimique Belge
536. United Network for Organ Sharing 
537. United Parcel Service
538. United Therapeutics
539. United Drug Distributors
540. University of Alabama
541. University of Oxford
542. University of Pennsylvania
543. Unsworth Global Logistics
544. Upperton Pharma Solutions
545. U.S. Army Medical Research and Materiel Command
546. US WorldMeds
547. Valeant Pharmaceuticals
548. Validated Delivery Solutions
549. Vanda Pharmaceuticals
550. va-Q-tec
551. VCK Logistics
552. Venz Express
553. Vericel
554. VersaCold Logistics Services
555. Vertex Pharmaceuticals
556. Vesco-MTO
557. Vestfrost 
558. Vetter Pharma
559. Vietnam Medical Equipment
560. VTS
561. Walgreens
562. Wayocom Labs
563. Woodfield Distribution
564. Wellstat Therapeutics
565. World Courier
566. Worthington Industries
567. Wuxi Yushou Medical Applicances
568. Wyeth
569. X2 Cold Chain
570. XPO Logistics
571. Yourway Transport
572. Yusen Logistics 
573. ZacPak
574. Zebraxx
575. Zero Appliances
576. Zeusch Aviation
577. Zhendre
578. Zhuhai Eastsun Technology
579. ZillionSource Technologies
580. Zipline
581. Zuellig Pharma

Request Customization

Please select a suitable option for customization in the report

PRICING DETAILS

USD 3,499

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print read more

This license grants the right of use of the purchased report by the employees of a business unit at a particular site / office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple read more

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm / enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the read more

Discounts available for multiple report purchases
sales@rootsanalysis.com